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PHOTOLABILE LINKER FOR THE excess of hydrazine , which complicates post - cleavage puri 
SOLID - PHASE SYNTHESIS OF fication . Such hydrazinolysis is neither generally compatible 
HYDRAZIDES AND PYRANOPYRAZOLES with the Boc / Bzl protecting group strategy , as benzyl esters 
readily react with hydrazine , nor the base - labile amino 
CROSS - REFERENCE TO RELATED protecting groups Phth , For , Fmoc , Dde and Nps , and 
APPLICATION ( S ) typically associated with several side - reactions causing low 
yields of desired peptides , such as those containing side 
This is a U . S . national stage entry of International Patent chain - protected cysteine , aspartic or glutamic acid recidues . 
Application No . PCT / EP2014 / 069392 , filed on Sep . 11 , To bypass such problems , synthetic strategies that are 
2014 , which claims priority to European Patent Application 10 based on special hydrazine resins have been proposed . Wang 
No . 14155016 . 0 , filed on Feb . 13 , 2014 , and European et al . ( Wang , S . S . ; Merrifield , R . B . , J . Am . Chem . Soc . 1969 , 
Patent Application No . 13183944 . 1 , filed on Sep . 11 , 2013 , 91 , 6488 . Wang , S . S . , J . Am . Chem . Soc . 1973 , 95 , 1328 . 
the entire contents of all of which are fully incorporated Wang , S . S . ; J . Org . Chem . 1975 , 40 , 1235 ) have reported 
herein by reference . methods for synthesizing peptide hydrazides using alkoxy 
carbonyl hydrazide resins . Release of peptides from the 
SEQUENCE LISTING linkers required 50 - 95 % TFA for 2 hours . Other strategies 
have relied on commercial trityl and 2 - C1 - trityl resins fol 
The instant application contains a Sequence Listing which lowed by solid - phase substitution of chloride with hydrazine 
has been submitted electronically in ASCII format and is to afford a trityl - based hydrazine linker construct ( Stavro 
hereby incorporated by reference in its entirety . Said ASCII 20 poulos , G . ; Gatos . D . ; Magafa , V . ; Barlos , K . , Lett . Pept . 
copy , created on Jun . 6 , 2016 , is named 030547 - 9044 Sci . , 1996 , 2 , 315 - 318 ) . Post - synthetic release of compounds 
USOO SL . txt and is 1 , 472 bytes in size . was achieved by treating the resin - hydrazides with 1 % TFA 
in AcOH - TFE - DCM ( 1 : 2 : 7 ) . These linkers are nevertheless TECHNICAL FIELD facing several limitations . Firstly , they do not tolerate C - ter 
minal glutamine , asparagine or aspartic acid recidues ( Fang , 
The present invention relates to photolabile hydrazine G . - M . : Li , Y . - M . : Shen . E : Huang , Y . - C . : Li . J . - B . . Lin . Y : 
linkers , which are capable of releasing hydrazide derivatives Cui , H . - K . ; Liu , L . Angew . Chem . , Int . Ed . 2011 , 50 , 
upon UV irradiation . The linker allows for a new peptide 7645 - 7649 . Campayo , L . ; Jimenez , B . ; Manzano , T . ; 7615 _ 7610 Can 
chemical synthesis strategy in which the crude peptide Navarro , P . Synthesis 1985 , 197 - 200 ) but also other peptide hydrazide may be ligated directly one - pot ) to a Cys - 30 hydrazides remain challenging to synthesize . Secondly , the 
functionalized peptide . Furthermore , the linker unit can be use of acidic reaction conditions for liberation of material 
applied to synthesize combinatorial libraries of biological from the solid support may be a synthetic disadvantage , as interesting pyranopyrazoles . some compounds and protecting groups , e . g . , Boc and Trt 
are not compatible with acids . Finally , the use of acid - labile BACKGROUND OF THE INVENTION linker strategies also limits the range of chemical transfor 
mations applicable to the synthesis of hydrazide derivatives . Organic hydrazides are an essential class of molecules Thus , there exists in the art a need for other cleavage 
with a wide spectrum of important properties . A sense of its principles that are attractive for the introduction of chemical importance can be garnered from the observation that the diversity including hydrazide functionality . 
antitubecular drug isoniazid contains this structural motif . 40 
Furthermore , organic hydrazides are versatile building BRIEF DESCRIPTION OF THE INVENTION blocks for the synthesis of pharmacologically relevant 
hydrazones and heterocycles as well as advanced materials . Photolysis offers a method for cleavage , which is fully 
Peptide hydrazides have been widely utilized in bioconju - orthogonal to chemical methods and thus can provide a 
gation reactions to form glyco - conjugates and more recently 45 solution to the problems discussed above . Furthermore , 
emerged as powerful precursors for peptide ligation . How photolytic cleavage offers exceedingly mild conditions , 
ever , their applicability may be limited in two respects : 1 ) which are attractive for direct applications in biochemical peptide hydrazides remain challenging to synthesize and reactions where contamination with cleavage reagents is 
require post - synthesis purification , which is a laborious , undesired 
time - consuming process associated with loss of valuable 50 In a first aspect the present invention relates to a photo 
material ; and 2 ) current peptide hydrazide synthesis strate - labile hydrazine linker which is suitable for synthesis of 
gies are not compatible with all amino acid residues nor their peptide hydrazides and dihydropyrano [ 2 , 3 - c ] pyrazoles on a typically modified side - chain derivatives . Therefore , an effi solid support . 
cient and mild method for peptide hydrazide synthesis The photolabile hydrazine linker has the formula I : 
would significantly improve these techniques . 55 
Given the importance of hydrazide derivatives in drug and 
probe discovery efforts , methods for the solid - phase parallel 
and combinatorial synthesis of protected hydrazides have 
been subject to many studies . Peptide hydrazides may be 
directly synthesized from solid - supported ester - linked pep - 60 
tides by hydrazinolysis ( Merrifield , R . B . , Adv . Enzymol . NH – NHR 1969 , 32 , 221 . Chang , J . K . ; Shimizu , M . ; Wang , S . S . , J . 
Org . Chem . 1976 , 41 . 3255 . Merrifield , R . B . , J . Am . Chem . 
Soc . 1963 , 85 , 2149 . Perlow , D . S . ; Erb , J . M . ; Gould , N . P . ; 
Tung , R . D . Freidinger , R . M . Williams , P . D . ; Veber , D . F . , 65 wherein R * is a bond OR ' , where R ' represents hydrogen , 
J . Org . Chem . 1992 57 , 4394 . Wang , S . S . J . Org . Chem . C1 - 12 alkyl or substituted C1 - 10 alkyl , aryl , substituted 
1976 , 41 , 3258 ) . However , this strategy often requires an aryl , heteroaryl , substituted heteroaryl or — ( CH2 CH2 — 
35 
n 
NO2 
D * 
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wherein 
mi 
0 ) - m , wherein R is H or a protecting group , m is an integer 
from 1 - 100 , and n is an integer from 1 to 10 . 
In one embodiment , the photolabile hydrazine linker is a 
compound , wherein R * is OH or OR ' , where R ' represents 
C1 - 12 alkyl or substituted C1 -10 alkyl , aryl , substituted aryl , 
heteroaryl , substituted heteroaryl or ( CH , CH , 
- 0 ) - m ; wherein R is hydrogen or a protecting group , m is 
an integer from 1 - 100 and n is an integer from 1 to 10 , 
preferably from 2 to 3 , such as from 310 or n 18 J . preferably from 2 to 5 , such as from 3 to 5 or n is 3 . 
In a second aspect , the present invention relates to a 
method for the synthesis of a photolabile hydrazine linker 
according to the present invention , wherein R * is OH and R 
is a protecting group , comprising the steps of 
a ) reacting a compound of formula 2 : 
is a functionalized solid support and PG is a protecting 
group . 10 10 The solid support comprising an immobilized protected 
hydrazine - functionalized photolabile linker may be synthe 
s ized by reacting a functionalized solid support with a 
protected hydrazine - functionalized photolabile linker 
according to the present invention defined above , wherein 
15 R * is OH and R is a protecting group . 
In one embodiment of the invention , the connection 
between the solid support and the protected hydrazine 
functionalized photolabile linker comprises a spacer and / or 
an orthogonally cleavable linker . 
20 In another embodiment , the solid support comprising a 
protected hydrazine - functionalized photolabile linker has 
the following formula : 
R - 0 
25 
wherein R ' represent C1 -8 alkyl , aryl , heteroaryl or 
- ( CH2CH20 ) m , m = 1 - 100 , n is an integer 
from 1 to 10 with PG - carbazate , where PG is a 
protecting group to obtain a compound of formula 3 : NH – NHPG 30 NH 
NO 
wherein 
35 no one NH NH – NHPG ONHR - Ó - 
is an amino - functionalized solid support and PG is a pro 
b ) hydrolyzing the compound of formula 3 to obtain a 40 tecting group . 
compound of formula 4 : In a further embodiment , the present invention includes a 
solid support having the formula 
NO2 
45 NO2 
voor de NH NHPG HN - NH2 HO 50 
A third aspect of the present invention relates to a solid 
support comprising the protected hydrazine - functionalized he protected hydrazine - functionalized photolabile linker according to the present invention having 
the formula : 
wherein 
NO2 
6 der HN - NHPG is a functionalized solid support , wherein the connection between the solid support and the hydrazine - functionalized photolabile linker optionally comprises a spacer and / or an orthogonally cleavable linker . In yet another embodiment , the present invention includes a solid support comprising an immobilized hydrazine - func 
tionalized photolabile linker having the formula 
65 
US 9 , 850 , 275 B2 
NO . NO2 
- NH 
15 
HN 
R3 
high purity and excellent yield . it is envisaged that this 
one - pot strategy may enable more convergent protein syn 
thesis and render it even more complementary to native 
chemical ligation . 
In a sixth aspect , the present invention relates to the use HN - NH , of the hydrazine - functionalized photolabile linker of the 
present invention for the synthesis of dihydropyrano [ 2 , 3 - c ] 
pyrazoles . A two - step synthetic protocol followed by pho 
10 tolytic release provided structurally diverse dihydropyrano wherein the connection between the solid support and the 10 [ 2 , 3 - c ] pyrazoles in excellent purity . Accordingly , the present hydrazine - functionalized photolabile linker optionally com invention also concerns a method for the synthesis of prises a spacer and / or an orthogonally cleavable linker . dihydropyrano [ 2 , 3 - c ] pyrazoles of the formula : In a fourth aspect of the present invention , it relates to the 
synthesis of peptide hydrazides , wherein the method com 
prises the steps of : 
a ) providing a solid support comprising an immobized 
hydrazine - functionalized photolabile linker according NH2 
to the present invention , 
b ) coupling a first N - protected amino acid moiety to said 20 
immobilized hydrazine - functionalized photolabile 
linker , 
c ) deprotecting said coupled N - protected amino acid 
moiety , 
d ) coupling a second N - protected amino acid moiety to 25 
said immobilized amino acid moiety , wherein R , is selected from C1 - 8 alkyl , aryl , mono - or e ) deprotecting said coupled N - protected amino acid multiply - substituted aryl , heteroaryl , mono - or multiply moiety , 
f ) repeating said coupling and deprotecting steps d and e substituted heteroaryl , where the substituents may be C - Cg 
as many times as necessary to synthesize an immobi - 30 alkyl , C7 - C , alkoxy , halogen , nitrile or nitro and Rz is 
lized peptide as desired , selected from aryl , mono - or multiply - substituted aryl , het 
g ) cleaving said immobilized hydrazine - functionalized eroaryl and substituted heteroaryl , where the substituents are 
peptide from the solid support by irradiation of the the same or different and represent C , - C , alkyl , C , - C , 
photolabile linker to obtain the peptide hydrazide . alkoxy , halogen , nitrile or nitro comprising the steps of : 
In one embodiment , the immobilized peptide is cleaving 35 a ) providing a solid support comprising a hydrazine 
from the solid support by irradiation in the presence of functionalized photolabile linker as defined above , 
acetone / CH , CN to obtain a peptide hydrazide protected as it b ) reacting said hydrazine - functionalized photolabile corresponding acetone hydrazone which optionally is depro linker with a B - keto ester with the formula : tected in the presence of water . 
The amino acid moieties are selected among all natural 40 
and unnatural amino acids and derivatives thereof . The 
amino acid moiety may also be composed of two or more 
natural and / or unnatural amino acids or derivatives thereof . 
Preferably , the amino acids are selected among the natural 
occurring amino acids . 45 
The synthesis strategy shows excellent compatibility with 
peptide composition , notably all 20 naturally occurring wherein R , is C , - C , alkyl , preferably methyl or ethyl , 
a - amino acid residues ( even the side - chain protected ana to obtain an immobilized 1H - pyrazol - 5 ( 4H ) - one 
logs ) were accepted at the C - terminal hydrazide moiety . The with formula : 
linker is compatible with most commonly used protecting 50 
groups for SPPS and remains intact throughout the multi 
step peptide synthesis . 
Products are ultimately released as hydrazides ( in situ 
trapped as acetone - derived hydrazone derivatives ) from the 
solid support in high purity using light . 55 
In a fifth aspect of the present invention , the invention 
relates to the use of the hydrazine - functionalized photolabile 
linker of the present invention for chemical synthesis of 
oligo - or polypeptides . Accordingly , the present invention 
also concerns a method for the synthesis of oligo - or 60 
polypeptides , which method comprises the steps of 1 ) 
obtaining a peptide hydrazide or acetone hydrazone pro 
tected peptide hydrazide in a method as disclosed above , and c ) reacting the 1H - pyrazol - 5 ( 4H ) - one with an aldehyde 2 ) coupling said peptide hydrazide with a peptide in a Rz - CO , wherein Rz is selected from aryl , substituted 
ligation reaction to obtain an oligo - or polypeptide . 65 aryl , heteroaryl and substituted heteroaryl , in the pres 
The direct ligation of a crude peptide hydrazide to a ence of malononitrile to obtain an immobilized dihy 
Cys - functionalized peptide provided a 10 - mer peptide in dropyrano [ 2 , 3 - c ] pyrazole with the formula : 
RI O - R2 
NO2 
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re 
CN 
FIG . 16 shows the RP - HPLC of crude 80 and 90 after 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 90 : Rt = 2 . 07 
( m / z = 612 . 4 ) , 80 : Rt = 2 . 26 ( m / z = 652 . 5 ) . 
NH2 FIG . 17 shows the RP - HPLC of crude 8 and 9q after 
5 photorelease in CH3CN / acetone ( 1 : 4 ) , where 9q : Rt = 1 . 56 
( m / z = 537 . 3 ) , 8q : Rt = 1 . 77 ( m / z = 577 . 3 ) . 
FIG . 18 shows the RP - HPLC of crude 87 and 99 after 
photorelease in CH2CN / acetone ( 1 : 4 ) , followed by removal 
of excess acetone by evaporation and addition of water / 
10 CH2CN ( 1 : 4 ) , where 9q : Rt = 1 . 56 ( m / z = 537 . 3 ) , 8q : Rt = 1 . 77 
( m / z = 577 . 3 ) . 
FIG . 19 shows the RP - HPLC of crude 8r and 9r after d ) cleaving said immobilized compound from the solid photorelease in CH CN / acetone ( 1 : 4 ) , where 9r : Rt = 1 . 72 , 
support by irradiation of the photolabile linker to obtain 8r : Rt = 1 . 95 . 
the dihydropyrano [ 2 , 3 - c ] pyrazole . 15 FIG . 20 shows the RP - HPLC of crude 8r and 9r after 
photorelease in CH2CN / acetone ( 1 : 4 ) , followed by removal BRIEF DESCRIPTION OF THE DRAWINGS of excess acetone by evaporation and addition of water / 
CH , CN ( 1 : 4 ) , where 9r : Rt = 1 . 72 . 
FIG . 1 shows the RP - HPLC of crude Sa and 9a after FIG . 21 shows the RP - HPLC of crude 8s and 9s after 
photorelease in CH2CN / acetone ( 1 : 4 ) , where 9a : R = 1 . 41 , 20 photorelease in CH , CN / acetone ( 1 : 4 ) , where Is : Rt = 1 . 82 , 
8a : Rt = 1 . 64 . 8s : Rt = 2 . 03 . 
FIG . 2 shows the RP - HPLC of crude 8b and 9b after FIG . 22 shows the RP - HPLC of crude 8s and 9s after 
photorelease in CH3CN / acetone ( 1 : 4 ) , where 9b : Rt = 1 . 09 , photorelease in CH2CN / acetone ( 1 : 4 ) , followed by removal 
8a : Rt = 1 . 40 . of excess acetone by evaporation and addition of water / 
FIG . 3 shows the RP - HPLC of crude 8 and 9b after 25 CH3CN ( 1 : 4 ) , where 9s : Rt = 1 . 82 . 
photorelease in CH , CN / acetone ( 1 : 4 ) : followed by removal FIG . 23 shows the RP - HPLC of crude 8t and 9t after 
of excess acetone by evaporation and addition of water photorelease in CH3CN / acetone ( 1 : 4 ) , where 8t : Rt = 1 . 92 
CH , CN ( 1 : 4 ) . ( m / z = 550 . 4 ) , 9t : Rt = 2 . 18 ( m / z = 590 . 4 ) . 
FIG . 4 shows the RP - HPLC of crude 8c and 9c after FIG . 24 shows the RP - HPLC of crude 8t and 9t after 
photorelease in CH2CN / acetone ( 1 : 4 ) , where 8c : Rt = 6 . 31 , 30 30 photorelease in CHQCN / acetone ( 1 : 4 ) followed by removal 
9c : Rt = 8 . 21 . of excess acetone by evaporation and addition of water / CH , CN ( 1 : 4 ) . FIG . 5 shows the RP - HPLC of crude 8d and 9d after FIG . 25 shows the RP - HPLC of crude Su and Iu after photorelease in CH2CN / acetone ( 1 : 4 ) , where 8d : Rt = 1 . 58 photorelease in CH , CN / acetone ( 1 : 4 ) , where Iu : Rt = 2 . 32 ( m / z = 490 . 3 ) , 9d : Rt = 1 . 81 . ( m / z = 779 . 5 ) , 8u : Rt = 2 . 47 ( m / z = 819 . 5 ) . 
FIG . 6 shows the RP - HPLC of crude 27d and 28d after FIG . 26 shows the RP - HPLC of crude 8v and Iv after photorelease in CH2CN / acetone ( 1 : 4 ) , followed by removal photorelease in CH2CN / acetone ( 1 : 4 ) , followed by removal 
of excess acetone by evaporation and addition of water / of excess acetone by evaporation and addition of water / 
CH2CN ( 1 : 4 ) , where 28d : Rt = 1 . 58 . CH3CN ( 1 : 4 ) , where Ov : Rt = 2 . 31 ( m / z = 763 . 5 ) . 
FIG . 7 shows the RP - HPLC of crude 8e and 9e after 40 FIG . 27 shows the RP - HPLC of crude 8w and 9w after 
photorelease in CH3CN / acetone ( 1 : 4 ) . photorelease in CH2CN / acetone ( 1 : 4 ) , where Iw : Rt = 2 . 07 
FIG . 8 show the RP - HPLC of crude 8e and le after ( m / z = 584 . 3 ) , Sw : Rt = 2 . 28 ( m / z = 624 . 4 ) . 
photorelease in CH3CN / acetone ( 1 : 4 ) , followed by removal FIG . 28 shows the RP - HPLC of crude 8w and 9w after 
of excess acetone by evaporation and addition of water / photorelease in CH3CN / acetone ( 1 : 4 ) followed by removal 
CH , CN ( 1 : 4 ) , where 9e : Rt = 1 . 73 . 45 of excess acetone by evaporation and addition of water / 
FIG . 9 shows the RP - HPLC of crude 8h and 9h after CH2CN ( 1 : 4 ) . 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 9h : Rt = 1 . 81 FIG . 29 shows the RP - HPLC of crude 8x and 9x after 
( m / z = 464 . 4 ) ) , 8h : Rt = 1 . 83 ( m / z = 504 . 4 ) . photorelease in CH2CN / acetone ( 1 : 4 ) , where 9x : Rt = 2 . 01 
FIG . 10 shows the RP - HPLC of crude 8i and 9i after ( m / z = 831 . 5 ) , 8x Rt = 2 . 16 ( m / z = 871 . 5 ) . 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 9i : Rt = 1 . 56 50 FIG . 30 shows the RP - HPLC of crude 9x and 8x after 
( m / z = 524 . 3 ) , Si : Rt = 1 . 77 ( m / z = 564 . 4 ) . photorelease in CH CN / acetone ( 1 : 4 ) followed by removal 
FIG . 11 shows the RP - HPLC of crude 8j and 9j after of excess acetone by evaporation and addition of water / 
photorelease in CH3CN / acetone ( 1 : 4 ) , where 9j : Rt = 1 . 47 , 8j : CH2CN ( 1 : 4 ) , where 9x : Rt = 2 . 02 ( m / z = 831 . 5 ) , 8x : Rt = 2 . 16 
Rt = 1 . 71 . ( m / z = 871 . 5 ) . 
FIG . 12 shows the RP - HPLC of crude 8k and 9k after 55 FIG . 31 shows the RP - HPLC of crude 8y and 9y after 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 9i : Rt = 1 . 74 , 8i : photorelease in CH , CN / acetone ( 1 : 4 ) followed by removal 
Rt = 1 . 98 . of excess acetone by evaporation and addition of water / 
FIG . 13 shows the RP - HPLC of crude 81 and 91 after CH2CN ( 1 : 4 ) , where 8y : Rt = 1 . 76 ( m / z = 616 . 5 ) , 9y : Rt = 1 . 93 , 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 91 : Rt = 1 . 35 , Rt = 1 . 07 : 8y - Boc . 
81 : Rt = 1 . 65 . 60 FIG . 32 shows the RP - HPLC of crude 8z and 9z after 
FIG . 14 shows the RP - HPLC of crude 8m and Im after photorelease in CH , CN / acetone ( 1 : 4 ) , where 8z : Rt = 0 . 75 . 
photorelease in CH , CN / acetone ( 1 : 4 ) , where 9m : Rt = 1 . 50 , FIG . 33 shows the RP - HPLC of crude 8z and 9z after 
8m : Rt = 1 . 77 . photorelease in CH2CN / acetone ( 1 : 4 ) followed by removal 
FIG . 15 shows the RP - HPLC of crude 8m and 9m after of excess acetone by evaporation and addition of water / 
photorelease in CH3CN / acetone ( 1 : 4 ) , followed by removal 65 CH CN ( 1 : 4 ) , where 8z : Rt = 0 . 75 . 
of excess acetone by evaporation and addition of water / FIG . 34 shows the RP - HPLC of crude Saa and 9aa after 
CH , CN ( 1 : 4 ) , where 9m : Rt = 1 . 50 . photorelease in CH CN / acetone ( 1 : 4 ) followed by removal 
US 9 , 850 , 275 B2 
of excess acetone by evaporation and addition of water / FIG . 49 shows the RP - HPLC of crude 18c after photo 
CH2CN ( 1 : 4 ) , where 9aa : Rt = 1 . 55 , Saa : Rt = 1 . 79 . release in H2O / MeOH ( 1 : 4 ) , where 18c : Rt = 1 . 85 ( Rt = 1 . 94 
FIG . 35 shows the RP - HPLC of crude Sab and Sab after corresponds to 2 , 4 - dihydro tautomer ) . 
photorelease in CH CN / acetone ( 1 : 4 ) , where 9ab : Rt = 1 . 63 FIG . 50 shows the RP - HPLC of crude 12d after photo 
( m / z = 579 . 4 ) , Sab : Rt = 1 . 83 ( m / z = 619 . 5 ) . 5 release in H , O / MeOH ( 1 : 4 ) , where 12d : Rt = 1 . 65 . 
FIG . 36 shows the RP - HPLC of crude Sab and gab after FIG . 51 shows the RP - HPLC of crude 12e after photo 
photorelease in CH , CN / acetone ( 1 : 4 ) followed by removal release in H , O / MeOH ( 1 : 4 ) , where 12e : Rt = 1 . 68 ( Rt = 1 . 74 
of excess acetone by evaporation and addition of water corresponds to 2 , 4 - dihydro tautomer ) . 
CH3CN ( 1 : 4 ) . FIG . 52 shows the RP - HPLC of crude 12f after photore 
FIG . 37 shows the RP - HPLC of crude Sac and 9ac after 10 lease in H2O / MeOH ( 1 : 4 ) , where 12f : Rt = 1 . 81 ( Rt = 1 . 87 
photorelease in CH , CN / acetone ( 1 : 4 ) followed by removal corresponds to 2 , 4 - dihydro tautomer ) . 
of excess acetone by evaporation and addition of water / FIG . 53 shows the RP - HPLC of crude 12g after photo 
CH2CN ( 1 : 4 ) , where Sac : Rt = 1 . 64 ( m / z = 451 . 3 ) , Sac : release in H2O / MeOH ( 1 : 4 ) , where 12g : Rt = 1 . 72 ( Rt = 1 . 78 
Rt = 1 . 89 ( m / z = 491 . 3 ) . corresponds to 2 , 4 - dihydro tautomer ) . 15 FIG . 54 shows the RP - HPLC of crude 12h after photo FIG . 38 shows a RP - HPLC of 9ac . release in H , O / MeOH ( 1 : 4 ) , where 12h : Rt = 1 . 47 . FIG . 39 shows the RP - HPLC of crude 8ad and had after 
photorelease in CH CN / acetone ( 1 : 4 ) , where Sac : Rt = 1 . 76 DETAILED DESCRIPTION OF THE ( m / z = 562 . 5 ) , 9ac : Rt = 1 . 98 ( m / z = 602 . 5 ) . INVENTION 
FIG . 40 shows the RP - HPLC of crude Sac and 9ac after 20 
photorelease in CH CN / acetone ( 1 : 4 ) followed by removal The photolabile hydrazine linker of the present invention 
of excess acetone by evaporation and addition of water is based on the o - nitro - veratryl group , which is capable of 
CH , CN ( 1 : 4 ) , where Sac : Rt = 1 . 76 ( m / z = 562 . 5 ) . releasing hydrazide derivatives upon UV irradiation . The 
FIG . 41 shows an HPLC of compound 14 . linker allows for a new solid - phase peptide synthesis ( SPPS ) 
FIG . 42 shows an HPLC of compound 25 strategy which is fully orthogonal to the most commonly 
used protecting groups and chemical methods in SPPS and 
shows excellent compatibility with peptide composition , 
notably all 20 naturally occurring a - amino acid residues 
( even in their side - chain protected form ) are accepted in the 
30 C - terminal of the peptide hydrazides . Furthermore , the 
linker unit can be applied to synthesize combinatorial librar 
ies of biological interesting heterocyclic compounds , e . g . 
pyranopyrazoles . 
O = s = 0 Abbreviations 
HNNH 
Fmoc = fluorenylmethyloxycarbonyl - removed by base , 
such as piperidine . 
Boc = t - butyloxycarbonyl - removed by acid , such as HC1 
40 and CF3COOH . 
Trt = trityl removed by acid , such as HCl and CF3COOH 
Alloc = allyloxycarbonyl - removed by tetrakis ( triphenyl 
phosphine ) palladium ( 0 ) in a mixture of methylene chloride , 
acetic acid , and N - Methylmorpholine 
45 tBu = tert - butyl - removed by acid , such as HCl and 
CF3COOH . 
Cbz - carbobenzyloxy - removed by hydrogenolysis . 
Bn = benzyl - removed by hydrogenolysis . 
SiRz , where R can be combinations of different groups . 
50 Common silyl protective groups are trimethylsilyl ( TMS ) , FIG . 43 shows an HPLC of crude H - Leu - Tyr - Arg - Ala tert - butyldiphenylsilyl ( TBDPS ) , tert - butyldimethylsilyl Tyr - NHNH , ( 13 ) . ( TBS / TBDMS ) and triisopropylsilyl ( TIPS ) , [ 2 - ( trimethyl 
FIG . 44a shows the crude RP - HPLC after 2h of the silyl ) ethoxy ] methyl ( SEM ) - removed with acids or fluo ligation with cysteine , where 16 : Rt = 6 . 74 , 13b : Rt = 8 . 74 . rides such as HF and tetra - n - butylammonium fluoride . 
FIG . 44b shows the crude RP - HPLC after 12h of the 55 Larger R - substituents increase resistance to hydrolysis . 
ligation with cysteine , where 16 : Rt = 6 . 74 , 13b : Rt = 8 . 80 . Rink - linker = 2 - ( 4 - amino ( 2 , 4 - dimethoxyphenyl ) methyl ) 
FIG . 45 shows the crude RP - HPLC after 12h of the phenoxylacetic acid 
formation of 15 , where 15 : Rt = 7 . 19 , 14 : Rt = 5 . 34 , 13b : Rink amide linker : 4 - [ ( 2 , 4 - dimethoxyphenyl ) ( Fmoc - amino ) 
Rt = 8 . 53 . methyl ] phenoxyacetic acid 
FIG . 46 shows the UPLC - MS traces corresponding to 60 NEM : N - ethyl morpholine . 
peak rt = 7 . 10 . PEGA : polyethylene glycol dimethyl acrylamide . 
FIG . 47 shows the RP - HPLC of crude 12a after photo TBTU : O - ( benzotriazol - 1 - yl ) - N , N , N ' , N - tetramethyluro 
release in H2O / MeOH ( 1 : 4 ) , where 12a : Rt = 1 . 82 ( Rt = 1 . 90 nium tetrafluorobrate 
corresponds to 2 , 4 - dihydro tautomer ) . HATU : O - ( 7 - azabenzotriazol - 1 - yl ) - N , N , N ' , N ' - tetramethyl 
FIG . 48 shows the RP - HPLC of crude 12b after photo - 65 uronium hexafluorophosphate 
release in H2O / MeOH ( 1 : 4 ) , where 12b : Rt = 1 . 77 ( Rt = 1 . 84 TLC : Thin layer chromatography 
corresponds to 2 , 4 - dihydro tautomer ) . HFIP : hexaflouroisopropanol 
35 
NH 
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ality 
TFA : trifluoroacetic acid used for linker attachment and / or synthesis . Suitable solid 
HPLC : _ High - performance liquid chromatography support materials typically will be the type of material 
HDAC : histone deacetylase commonly used in peptide and polymer synthesis . To 
pyBOP : benzotriazol - 1 - yl - oxytripyrrolidinophosphonium improve swelling properties quite porous beads , resins , or 
hexafluorophosphate other supports work well and are often preferable . Particu 
DIPEA : N , N , Diisopropylethylamine larly preferred materials include polystyrene , polypropyl 
DMF : Dimethylformamide ene , polyethylene glycol and polyacrylamide resins , e . g . 
NMP : N - methyl - 2 - pyrrolidone TentaGel® or Chemmatrix® . 
SPPS : solid - phase peptide synthesis Activating Group : 
PBS : phosphate buffered saline 10 refers to a group which , when attached to a particular 
PG - carbazate : hydrazine protecting group - hydrazinocar - functional group , renders that site more reactive toward 
boxylate . For example tert - butyl carbazate ( H2N - NHBoc ) . covalent bond formation with a second functional group . 
The group of activating groups which are useful for a 
Definitions carboxylic acid include an amino group simple ester groups , 
15 anhydrides , and acid chlorides . The ester groups include 
Support / Solid Support / Solid Phase . alkyl , aryl and alkenyl esters and in particular esters of 
Nature of the solid support : Solid supports that can be 4 - nitrophenol , N - hydroxysuccinimide , N - hydroxybenzotri 
functionalized with the linker may be of any shape or size , azole , and pentafluorophenol . Other activating groups are 
such as roughly spherical ( beads ) or a planer surface . The known to those skilled in the art . 
solid supports need not necessarily be homogenous in size , 20 Immobilization : 
shape or composition ; although the solid supports usually The choice of functionality used for binding the linker to 
and preferably will be uniform . the solid support will depend on the type of solid support . 
The physical properties of the solid support , and the Conditions for coupling monomers to solid supports through 
applications to which it can be utilized , vary with the a wide variety of functional groups are known . For example , 
material from which the support is constructed , the amount 25 the carboxyl group of the linker can be activated by con 
of cross - linking , as well as the linker and handle being used . verting it to the corresponding — COP group wherein Pis an 
It is believe that supports should have the minimum amount activating group as defined above . This can then be coupled 
of cross - linking to confer stability . This should result in a to an amino or hydroxyl group of the solid support . 
well - solvated system where solid - phase synthesis and can be Protecting Group : 
carried out . Nonetheless , the characteristics of an efficient 30 refers to a chemical group protecting the hydrazine group 
solid support include : during chemical processing and exhibits the following char 
It must be physically stable and permit the rapid filtration acteristics : ( 1 ) reacts selectively with the desired function 
of liquids , such as excess reagents . ality ( NHNH , ) in good yield to give a derivative that is 
It must be inert to all reagents and solvents used during stable to the projected reactions for which protection is 
synthesis . desired ; ( 2 ) can be selectively removed from the derivatized 
It must swell extensively in the solvents used to allow for solid support to yield the desired functionality ; and ( 3 ) is 
penetration of the reagents . removable in good yields by reagents compatible with the 
It must allow for the attachment of the photolabile linker other functional group ( s ) generated in such projected reac 
of the present invention tions . Examples of protecting groups can be found in Greene 
There are three primary types of solid supports : 40 et al . ( 1991 ) Protective Groups in Organic Synthesis , 2nd Ed . 
Gel - type supports : These are highly solvated polymers ( John Wiley & Sons , Inc . , New York ) . Preferred examples 
with an equal distribution of functional groups . This are Fmoc , Boc , Trt , Alloc , tBu , Cbz , Bn , SiRz 
type of support is the most common , and includes : N - Terminal Protecting Group : 
Polystyrene : Styrene cross - linked with 1 - 2 % divinyl Amino acids are added in excess to ensure complete 
benzene 45 coupling during each synthesis step in SPPS , and without 
Polyacrylamide : A hydrophilic alternative to polysty N - terminal protection , polymerization of unprotected amino 
rene acids could occur , resulting in low peptide yield or synthesis 
Polyethylene glycol ( PEG ) : PEG - Polystyrene ( PEG failure . N - terminal protection requires an additional step of 
PS ) is more stable than polystyrene and spaces the removing the protecting group , termed deprotection , prior to 
site of synthesis from the polymer backbone 50 the coupling step , creating a repeating design flow as fol 
PEG - based supports : Composed of a PEG - polypropyl - lows : 
ene glycol network or PEG with polyamide or poly - Protecting group is removed from the trailing amino acids 
styrene in a deprotection reaction . 
Surface - type supports : Many materials have been devel Deprotection reagents are washed away to provide a clean 
oped for surface functionalization , including controlled 55 coupling environment . 
pore glass , cellulose fibers , and highly cross - linked Protected amino acids dissolved in a solvent such as 
polystyrene . dimethylformamide ( DMF ) combined with coupling 
Composites : Gel - type polymers supported by rigid matri reagents are pumped through the synthesis column . 
ces . Coupling reagents are washed away to provide clean 
The chemically reactive groups with which such solid 60 deprotection environment 
supports may be derivatized are those commonly used for Two protecting groups ( t - Boc , Fmoc ) are commonly used 
solid phase synthesis , i . e . , amino and hydroxyl . in solid - phase peptide synthesis . Their lability is caused by 
For on - bead synthesis , the solid support is preferably the carbamate group which readily releases CO2 for an 
composed by polymeric beads , limited primarily by capacity irreversible decoupling step . 
for swelling , light permeability and the capacity for deriva - 65 Photolytic Cleavage : 
tization to attach any of a number of chemically reactive Photolytic cleavage is carried out on the hydrazine 
groups as well as compatibility with the synthetic chemistry functionalized photolabile solid support suspended in appro 
13 
R * 
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priate solvents by irradiation for an amount of time to allow molecular probes , they can help to better understand the 
the desired cleavage to take place . By changing the time of function of biological systems . 
illumination , from 0 to 100 % of the photolabile bonds are Optimized and fine - tuned analogues of peptidic sub 
cleaved . When the present invention is used as a production strates , inhibitors or effectors are also excellent analytical 
platform , it may be desirable to release as much as possible 5 tools and molecular probes for investigating signal trans 
in one step by choosing a sufficiently long time - length of duction pathways or gene regulation . 
illumination . A quality check of the synthesized compound Examples of commercially available unnatural amino 
may be incorporated by release of a small portion before acids ( from Sigma - Aldrich ) includes : R - amino acids ( 133 
release of the whole lot . and 12 ) , Homo - amino acids , Proline and Pyruvic acid 
Alternatively , one or more additional linkers may be 10 derivatives , 3 - substituted Alanine derivatives , Glycine 
included in the hydrazine - functionalized photolabile solid derivatives , Ring - substituted Phenylalanine and Tyrosine 
support for additional chemical or photolytic cleavage . Such Derivatives , Linear core amino acids , Diamino acids , 
additional linkers comprise base - labile , acid - labile , metal - D - amino acids and N - methyl amino acids . 
labile , safety - catch and photolabile linkers , known to per - 16 The Photolabile Hydrazine Linker 
sons skilled in the art . Other linkers may also be included in In a first aspect of the present invention , it relates to a 
order to optimize and verify the attachment chemistry . Such photolabile hydrazine linker which is suitable for synthesis 
linkers , such as for example the Rink linker , are known is the of peptide hydrazides and dihydropyrano [ 2 , 3 - c ] pyrazoles on 
art . a solid support . 
The energy needed in the photolysis step to cleave the 20 The photolabile hydrazine linker has the formula I : 
linker according to the present invention is provided by a 
360 nm light source , for example a 400W LED UV - lamp . 
For the release of synthesized compounds , e . g . from a NO2 
library of functionalized small molecules , photolytic cleav 
age is carried out on a hydrazine - functionalized photolabile 25 
solid support . In one example , set up to illustrate the present 
invention , the hydrazine - functionalized photolabile solid HN - NHR 
support 9 is suspended in appropriate solvents and cleaved 
by irradiating for a certain time at room temperature with 
360 nm light using a 400W LED UV - lamp . 30 
Spacer : wherein R * is OR ' , where R ' is H , alkyl , substituted alkyl or 
any flexible part of a molecule providing a connection ion a bond to a solid support ; R is H or a protecting group and ! between the solid support and the photolabile linker . Prior to n is an integer from 1 to 10 . 
attachment , it has one reactive functional group appropriate R * is OH or OR ' , wherein R ' is C1 - 12 alkyl or substituted 
for attachment to the support and one or more optionally 35 C1 - 10 alkyl , preferable C1 - 6 alkyl or substituted C1 . 6 alkyl , 
protected functional group appropriate for later further func - most preferable C - 4 alkyl or substituted C , 4 alkyl , such as 
tionalization , e . g . amine - protected amino acids with acti - methyl or ethyl or branched or unbranched propyl or butyl . 
vated carboxylic acid groups . The alkyl may be substituted with one or more groups 
Peptide / Oligopeptide : selected from alkyl , aryl , substituted aryl , heteroaryl , sub 
polymer comprising two to 20 naturally occurring amino 40 stituted heteroaryl . Substituents may be C , - C , alkyl , C . - C , 
acids and / or unnatural amino acids . It includes dipeptides , alkoxy , halogen , nitrile or nitro 
tripeptides , tetrapeptides , pentapeptides , etc . Ris H or a protecting group , where the protecting group 
Polypeptide : is selected from the group comprising Cbz ( Z ) , multiple 
a chain of more than 20 naturally occurring amino acids substituted methoxy - , nitro - , or chloro - Cbz ( including Z ( 4 
and / or unnatural amino acids . 45 MeO ) , Z ( 2 - NO2 ) , Z ( 4 - NO2 ) , Z ( 2 - C1 ) , Z ( 3 - C1 ), Z ( 2 , 4 - C1 ) , 
Naturally Occurring Amino Acids : and Z ( 3 , 5 - OMe ) ) , Ddz , Nvoc , Pz , Tmz , Bic , Bpoc , Azoc , 
20 canonical a - amino acids ( L - form ) that aminoacyl - iNoc Bocm Cyoc , Tcboc , Adoc , Adpoc , Iboc , Fmoc , Tsoc , 
tRNA synthetases use to build proteins in cells : isoleucine , Msc , Nsc , Bspoc , Bsmoc , Mspoc , Aloc , Teoc , Tipseoc , 
alanine , leucine , asparagine , lysine , aspartate , methionine , Pipoc , Poc , PTnm , Epoc , Mtr , Pmc , Pbf , Trt , 2 - C1 - Trt , Dmt , 
cysteine , phenylalanine , glutamate , threonine , glutamine , 50 Tmob , Tfa , Tos , o - Nbs , p - Nbs , DNBS , Bts , Nps , Dde , Nde , 
tryptophan , glycine , valine , proline , serine , tyrosine , argi Trt , Bzl and Acm . 
nine and histidine . The D - form of these amino acids may n is an integer from 1 to 10 , preferably from 2 to 5 , such 
also be found in nature or synthesized . as from 3 to 5 or n is 3 . 
Unnatural Amino Acids and Amino Acid Derivatives : The present invention further concerns a method for the 
Unnatural amino acids are non - proteinogenic amino acids 55 synthesis of the photolabile hydrazine linker , wherein R * is 
that either occur naturally or are chemically synthesized . OH and R is a protecting group , comprising the steps of 
Whether utilized as building blocks , conformational con a ) reacting a compound of formula 2 : 
straints , molecular scaffolds or pharmacologically active 
products , unnatural amino acids represent a nearly infinite 
array of diverse structural elements for the development of 60 
new leads in peptidic and non - peptidic compounds . Due to 
their seemingly unlimited structural diversity and functional 
versatility , they are widely used as chiral building blocks and 
molecular scaffolds in constructing combinatorial libraries . 
Drug discovery can benefit from novel , short - chain pep - 65 R - O 
tide ligand mimetics ( peptidomimetics ) with both enhanced 
biological activity and proteolytic resistance . Used as 
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- continued wherein R ' is alkyl or substituted alkyl and n is an integer 
from 1 to 10 with PG - carbazate , where PG is a pro 
tecting group to obtain a compound of formula 3 : 
??? 
NO , 
10 10 HN - NHPG 
1c 
R — Ó 
and b ) , hydrolyzing the compound of formula 3 to obtain 
a compound of formula 4 : 15 OH 
NO2 
NO2 
20 
HN - NHPG 
?? ld 25 
NO2 
Synthesis of the photolabile hydrazine linker 4 ( illustrated 
with Boc as the hydrazine protecting group and in Schema 
1A and R ' = ethyl ) may commence with the alkylation of 
acetovanilone la with ethyl - 4 - bromobutyrate followed by 30 
nitration , reduction and chlorination ( 1b - 1d ) to yield key 
intermediate benzylic chloride 2 ( Qvortrup , K . ; Nielsen , T . 
E . Chem . Commun . 2011 , 47 , 3278 - 3280 ) over four steps 
( Scheme 1A and 1B ) . 35 Substitution of chloride with tert - butyl carbazate gave 3 
and finally , hydrolysis of the ester moiety afforded the 
4 - ( 4 - ( 1 - ( 2 - ( tert - butoxycarbonyl ) hydrazinyl ) ethyl ) - 2 
methoxy - 5 - nitrophenoxy ) butanoic acid linker ( 4 ) in two 
steps . 40 
N 
Scheme 1A Synthesis of a Boc - protected hydrazine photolabile linker 4 NHBoc 
0 NO2 
3 
Mn 0 
3 
la 
NHBoc 
NO2 
2 Ot Mn OH 
65 If desired to have a different hydrazine protecting group ( PG ) in the linker , such a group may be introduced in step 
5 instead of Boc to give 3 ' and 4 ' : 
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_ NO2 NO2 
Min OH 
3 ' 4 
Scheme 1B . Synthesis of a Boc - protected hydrazine photolabile linker 4 where n = 3 and R ' = ethyl . 
NO2 
- 
Oxzato Sosabog 
1 ) Br ( CH2 ) 3CO2Et , 
K2CO3 , DMF , quant . 
2 ) HNO3 , Ac20 
3 ) NaBH4 , MeOH , quant . 
4 ) SOCl2 , CH2Cl2 
HO 
OH NO , HOE OEt NO2 
LiOH , THF , 
H20 
H2NNHBoc , 
K2CO3 , KI ,
DMF , 60° C . O ( $ 3 
NH NH 
BocHN BocHN 
3 
Immobilization of the Protected photolabile Hydrazine 35 group may be selected from amino , hydroxy , carboxy , 
Linker acrylo , maleimido , halo ( chloro , bromo , iodo ) , azido , alky 
For use of protected hydrazine - functionalized photolabile nyl , alkenyl , and nitro . 
linkers according to the invention in solid phase synthesis of In the case of using an amino group as the functional 
hydrazine functionalized polymers or heterocyclic com - group the immobilized protected hydrazine - functionalized 
pounds , the protected hydrazine - functionalized photolabile 10 photolabile linker has the following formula : 
linker is immobilized on a solid support by reacting a 
suitably functionalized solid support with said protected 
hydrazine - functionalized photolabile linker wherein R * is 
OH and R is a protecting group to obtain an immobilized 
protected photolabile hydrazine linker of the following 
formula : 
NO2 
45 . 
HN - NHPG 
NO , NH - 
50 
55 
The protecting group used for protecting the hydrazine 
group during the chemical synthesis is selected from the 
HN - NHPG group comprising Cbz ( Z ) , multiple substituted methoxy - , 
nitro - , or chloro Cbz ( including Z ( 4 - MeO ) , Z ( 2 - NO2 ) , Z ( 4 
NO2 ) , Z ( 2 - C1 ) , Z ( 3 - C1 ) , Z ( 2 , 4 - C1 ) , Z ( 3 , 5 - OMe ) , Ddz , Nvoc , 
Pz , Tmz , Bic , Bpoc , Azoc , iNoc Bocm Cyoc , Tcboc , Adoc , 
Adpoc , Iboc , Fmoc , Tsoc , Msc , Nsc , Bspoc , Bsmoc , Mspoc , wherein Aloc , Teoc , Tipseoc , Pipoc , Poc , PTnm , Epoc , Mtr , Pmc , 
Pbf , Trt , 2 - C1 - Trt , Dmt , Tmob , Tfa , Tos , o - Nbs , p - Nbs , 
dNBS , Bts , Nps , Dde , Nde , Trt , Bzl and Acm . Other 60 protecting groups would be known by the skilled person . 
The functionalized solid support may comprise a further 
( and orthogonal ) linker between the solid support and the 
functional group provided for binding the protected hydra 
is a functionalized solid support and PG is a protecting zine - functionalized photolabile linker according to the pres 
group . 65 ent invention . Such additional linkers may be used as 
The solid support is functionalized with a group suitable spacers and or in order to introduce further cleaving sites as 
for covalent binding to the protected linker . The functional defined above . 
NO2 
NH 
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The immobilized protected hydrazine - functionalized pho 
tolabile linker can be used in synthesis of hydrazine deriva 
tives such as hydrazide peptides and hydrazine functional 
ized heterocycles . The immobilized linker is prepared for 
such synthesis by removal of the protecting group from the HN - NH 
protected hydrazine - functionalized photolabile linker on the 
— 
solid support as illustrated in Schema 2 . 
However , synthetic difficulties were encountered in the 10 10 Synthesis of Peptide Hydrazides 
removal of the protecting group by conventional methods . The use of the protected photolabile hydrazine linker ( 4 , 
Exposing linker construct 5 to standard TFA / CH _ C12 ( 1 : 1 ) 4 ' ) was explored as a peptide hydrazide - releasing linker as 199 
Boc - and Trt - deprotection conditions resulted in formation d in formation described in general in the following and more specific in the described in genera 
of the corresponding trifluoroacetyl - functionalized hydra 15 example section . The invention is illustrated with R * being 
zine photolabile support . However , it was found that a mild OH or O - ethyl , the protecting group , PG , being Boc and n 
TMSOT / 2 , 6 - lutidine mediated Boc - deprotection resulted in being 3 Other meanings of R * , PG and n may be applied in 
clean conversion to the desired resin - bound photolabile a similar way . 
hydrazine - derivative 7 . Trt - deprotection may be accom An O - ( benzotriazol - 1 - yl ) - N , N , N ' , N ' - tetramethyluronium 
plished with dilute HCl in dioxane . tetrafluorobrate ( TBTU ) - mediated coupling of 4 to the com 
After removal of the protecting group from the linker , the mercially available amino support ( PEGAs . o ) proceeded 
solid support comprising the immobilized hydrazine - func with full conversion , as judged by conventional Kaiser test , 
tionalized photolabile linker has the following formula : to afford the protected hydrazine - functionalized photolabile 
25 support 5 . 
With an optimized Boc - deprotection protocol at hand , the 
application of the present linker was examined for the 
controlled synthesis and photolytic release of hydrazide 
30 peptides ( Scheme 2 ) . Peptides were synthesized via a Fmoc 
HN - NH2 . strategy using TBTU / NEM - mediated coupling reactions , 
and the ultimate photolytic cleavage was carried out by 
irradiating for 60 min at rt with 360 nm light using a 400W 
35 LED UV - lamp . To avoid any side reactions associated with 
wherein the released hydrazide - functionality , including the resin bound 2 - nitrosoacetophenone residues resulting from the 
photolysis step , the protolytic release was performed in 
40 acetone / CH3CN ( 3 : 2 ) , releasing the hydrazide group con 
veniently protected as its acetone hydrazine 8 . However , no 
separate deprotection step is required to free the hydrazide 
9 , as the acetone rapidly exchanges under the aqueous is a functionalized solid support . conditions commonly used in ligation and bioconjugation 
In the case of an amino - functionalized solid support , the reactions . Alternatively , co - evaporation of the acetone 
solid support comprising the immobilized hydrazine - func hydrazine 8 with water cleanly releases the free hydrazide 9 
tionalized photolabile linker has the following formula : without the need for further post - cleavage purification . 
Scheme 2 . Synthesis and photolytic release of peptide hydrazides 
NO2 
- NH2 , 
TBTU , NEM 
DMF 
TMSOTE , 
2 , 6 - lutidine 
CH2Cl2 NH 
NH 
- ó BocHN BOCHN 
= PEGA800 5 
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- continued NO2 
SPPS , 
NH NH 
NH HN - NH H N 
7 
the be NH2 hv ( 360 nm , 400 W LED ) 
acetone / CH3CN SEROWE CHCN H2O 100 m HO + HN HN HN 
8 O
All the 20 naturally occurring amino acid residues ( even Ligation of Peptide Hydrazides 
the side - chain protected analogs ) were accepted in the 75 The ligation of peptide hydrazides has been shown to be 
C - terminal position of the peptide - hydrazide ( table 1 ) . How particulary useful for protein chemical synthesis ( Fang , 
ever , peptide - hydrazides containing C - terminal Glu ( tBu ) G . - M . ; Li , Y . - M . ; Shen , F . ; Huang , Y . - C . ; Li , J . - B . , Lin , Y . ; and Asp ( tBu ) residues should be released just prior to use 
and / or stored as an acetone - solution , as storage of the free Cui , H . - K . ; Liu , L . Angew . Chem . , Int . Ed . 2011 , 50 , 
peptide hydrazides over longer time may result in degrada - 30 ! 7645 - 7649 ) . The application of linker 4 can be utilized in an 
tion into the corresponding 1 , 2 - diazepane - 3 , 7 - diones and efficient one - pot strategy , combining solid - phase synthesis , 
tetrahydropyridazine - 3 , 6 - diones , respectively . a mild photolytic release and the direct ligation of peptide 
hydrazides to provide the desired ligation product in high 
TABLE 1 yield . Such a strategy will significantly improve chemical 
protein synthesis and render it even more complementary to Peptide hydrazides ( 9a - 9ad ) synthesized according to Scheme 2 . Peptide In 
is disclosed as SEQ ID NO : 1 and peptide 9p is disclosed as SEQ ID NO : 2 . native chemical ligation . 
C - terminal 
Entry AA Product 
Qa 
9c 
9d 62337 Gly Ala Val Val 
Leu Leu 9e 9f 
Puritya 
> 95 % 
82 % 
> 95 % 
91 % 
> 95 % 
82 % 
87 % 
89 % 
87 % 
> 95 % 
> 95 % 
85 % 
> 95 % 
> 95 % 
9g 
9h Ile 
Met 
Phe 
91 
As an example of the applicability of the strategy , the 
40 ligation between model peptide hydrazide H - Leu - Tyr - Arg 
Ala - Tyr - NHNH2 ( SEQ ID NO : 2 ) ( 13 ) and H - Cys - OH was 
performed . Peptide hydrazide 13 was synthesized from 6 
and cleanly released as the acetone hydrazone by light . After 
45 removal of the excess acetone ( by a stream of nitrogen ) , an 
aqueous phosphate ( 0 . 2 M ) buffer containing 6 . 0 M guanidi 
num chloride followed by H - Cys - OH was added ( final 
peptide concentration of 1 . 5 and 2 . 0 mM , respectively ) . At 
a low pH ( 3 . 0 ) and - 10° C . , an aqueous NaNO2 solution was 
added to the ligation mixture . After 20 min , 4 - mercaptophe 
nylacetic acid was added , the pH value was adjusted to 7 . 0 
and the reaction left at room temperature for 12 h . Analysis 
of the reaction by HPLC showed a clean ligation reaction in 
55 85 % yield . 
Pro 
9m 
9n 
Naph - Phe - Gly - NHNH ) 
Naph - Ala - NHNH , 
Boc - Phe - Val - NHNH , 
Boc - Pro - Phe - Val - NHNH ) 
Naph - Phe - Leu - NHNH ) 
Boc - Pro - Phe - Leu - NHNH ) 
Boc - Ser ( Bzl ) - Pro - Leu - NHNH , 
Boc - Phe - Ala - Ile - NHNH2 
Boc - Leu - Phe - Met - NHNH ) 
Naph - Phe - NHNH ) 
Naph - Leu - Phe - NHNH , 
Boc - Phe - Pro - NHNH 
Naph - Phe - Pro - NHNH ) 
H - Leu - Tyr?tBu ) - Arg ( Pbf ) - Ala - Tyr ( tBu ) 
NHNH2 
Boc - Phe - Leu - Tyr ( tBu ) - NHNH ) 
H - Leu - Tyr - Arg - Ala - Tyr - NHNH2 
Boc - Phe - Ala - Tp - NHNH ) 
Boc - Phe - Ser ( Bzl ) - NHNH , 
Naph - Phe - Ser ( Bzl ) - NHNH ) 
Boc - Phe - Leu - ThrotBu ) - NHNH ) 
Boc - Ala - Tyr ( tBu ) - Asn ( Tt ) - NHNH 
Boc - Leu - Phe - Gln ( Trt ) - NHNH2 
Boc - Phe - Leu - Cys ( StBu ) - NHNH ) 
Boc - Ala - Tyr?tBu ) - Arg ( Pbf ) - NHNH , 
Boc - Val - Phe - His ( Boc ) - NHNH , 
Naph - His - NHNH , 
Naph - Lys ( Boc ) - NHNH2 
Boc - Ala - Phe - Lys ( B?c ) - NHNH , | Boc - Phe - AspotBu ) - NHNH ) 
Boc - Pro - Phe - GluotBu ) - NHNH2 
Tyr 
99 Trp 
Ser 9r 
9t 
Ou 
9v 
9w 
9x 
Thr 
Asn 
Gln 
Cys 
Arg 
His 
88 % 
> 95 % 
> 95 % 
> 95 % 
> 95 % 
87 % 
92 % 
90 % 
> 95 % 
> 95 % 
90 % 
> 95 % 
90 % 
> 95 % 
> 95 % 
83 % 
9y 
Lys 
9z 
9aa 
9ab 
9ac 
9ad 
Application of the linker for the synthesis of a larger 
peptide is shown in Scheme 4 . In this example , the 10 - mer 
60 peptide H - Leu - Tyr - Arg - Ala - Tyr - Cys - Lys - Tyr - Met - His - OH 
( SEQ ID NO : 3 ) ( 15 ) was successfully synthesized by 
ligating peptide hydrazide 13 with peptide fragment 14 
( SEQ ID NO : 4 ) ( Scheme 4 ) . using the one - pot protocol as 
disclosed above . The ligation proceeded as cleanly as 
reported by Liu and co - workers to provide the desired 
product in a high yield ( 93 % ) . 
Asp 
Glu 65 
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Scheme 4 . Application of linker construct 6 for the synthesis of a 10 - mer peptide 
HNNH2 
NH OH 
SPPS , 
then hv ( 360 nm , 
400 W LED ) NH2 and yesu N NH 
" ?? 
13 
One - pot H - Cys - Lys - Tyr - Met - His - OH ( 14 ) , NaNO2 , , then MPAA 
OH NH2 
HN 
NH HN 
NH NH 
HNIC 
HN HN 
NH 
- NH NH 
- NH2 
NH2 HN ?? 
OH 
NH 
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Synthesis of Dihydropyrano [ 2 , 3 - c ] Pyrazoles synthesis of dihydropyrano [ 2 , 3 - c ] pyrazoles through a two 
To demonstrate the potential of the linker for the genera - step procedure as outlined in Scheme 3 . Given the large 
tion of more elaborate heterocyclic structures in a combi - number of commercially available aldehydes and the easy 
natorial library format , the use of linker 4 for the synthesis 60 access to O - keto esters , this protocol represents a syntheti 
of structurally diverse dihydropyrano [ 2 , 3 - c ] pyrazoles was cally attractive route to dihydropyrano [ 2 , 3 - c ] pyrazole com 
investigated . binatorial libraries with high structural diversity conve 
Dihydropyrano [ 2 , 3 - c ] pyrazoles constitute an important niently introduced by substituents at the 3 - and 4 - position 
class of compounds with a wide range of biological prop ( R ' and Rº ) . R , is selected from alkyl , substituted alkyl , aryl , 
erties , such as anticancer , antimicrobial and antiinflamma - 65 substituted aryl , heteroaryl , substituted heteroaryl and R3 is 
tory activities . The application of the hydrazine - functional - selected from aryl , substituted aryl , heteroaryl , substituted 
ized photolabile support 6 can be used for the solid - phase heteroaryl . 
US 9 , 850 , 275 B2 
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Scheme 3 . Synthesis and photolytic release of dihydropyrano [ 2 , 3 - c ] pyrazoles . 
NO2 
R2 R3 , malono 
nitrile 
07 6 - 
US $ 23 
months 
Foloses 
R2 = Me , Et 
EtOH , 60° C . Et3N , EtOH NH 
10 
NO2 
hv ( 360 nm , 
400 W LED ) HN 
CN NH H20 / MeOH 
( 1 : 4 ) R3 
12 
11 
Substrate 
The use of linker 4 ( 4 ' ) for the generation of structural TABLE 2 - continued diverse dihydropyrano [ 2 , 3 - c ] pyrazoles was demonstrated 
by reacting the hydrazine - functionalized photolabile support Dihydropyrano [ 2 , 3 - c ] pyrazole derivatives 12a - 12h produced via Scheme 3 . 6 with the appropriate 3 - keto ester under basic conditions to 30 - 
produce the 1H - pyrazol - 5 ( 4H ) - one derivative 10 . After 
wards , 10 was reacted in a three - component base - catalyzed d in a three - component base - catalyzed Entry E puritya 
reaction with the corresponding aldehyde and malononitrile 
in a tandem Michael addition - Thorpe - Ziegler reaction fol > 95 % 
lowed by tautomerization to generate the desired dihydro - 35 
pyrano [ 2 , 3 - c ] pyrazole derivative 11 . The steps of synthesis 
and photolytic release of the dihydropyrano [ 2 , 3 - c ] pyrazoles 
( 12a - 12h ) were very clean ( Table 2 ) . 
12c 
40 TABLE 2 NC . 
Dihydropyrano [ 2 , 3 - clpyrazole derivatives 12a - 12h produced via Scheme 3 . 
Entry HN Entr Substrate 0 À Substrate puritya 
45 12a > 95 % 12d > 95 % 
NC . NE 
H?NN HN Ñ HNO HN 
T ]
> 95 % 12e 12e 12b > 95 % > % 
H?N Co . N H2N 
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TABLE 2 - continued 
28 
Example 1 
Dihydropyrano [ 2 , 3 - c ] pyrazole derivatives 12a - 12h produced via Scheme 3 . Linker Synthesis 
Entry Substrate purity 5 
Scheme 1 
12f 95 % 
10 ? 
quant . 
HNo N HaN 15 0H O
? 
12g 95 % 
? 
879 
NC 
?? 
H , No N 
12h NO2 90 % 
N02 
( . 
?? quant . ?? ??  HgNoN 12 EXAMPLES OH NO2 
81 % 
1d 
General Methods 
All reagents used were commercially available . All sol - 45 
vents were of HPLC grade . Solid - phase synthesis was 
carried out using plastic - syringe techniques . Flat - bottomed 
PE - syringes were fitted with PPE filters , Teflon® tubing and 
valves , which allow suction to be applied to the syringes . 
Acid - mediated release of products was carried out in glass 50 
vials . Products were analyzed using a Waters Alliance 2695 
HPLC system using Symmetry® C - 18 column 3 . 5 um , 
4 . 6x75 mm , column temp ; 25°C . , ( 1 ml / min . ) with detection 
at 215 nm and 254 nm using a diode array detector . Eluent 
A ( 0 . 1 % TFA in H2O ) and eluent B ( 0 . 1 % TFA in acetoni 
trile ) was used with a linear gradient ( 100 % A to 100 % B ) 
with a run time of 13 min . Analytical LC - MS analysis was 
performed on a Waters AQUITY UPLC system equipped 
with PDA and SQD MS detector ; column : AQUITY UPLC a 
BEHC181 . 7 um , 2 . 1×50 mm ; column temp : 65°C . ; solvent 
A : 0 . 1 % formic acid ( aq ) ; solvent B : 0 . 1 % formic acid 
( acetonitrile ) ; gradient : 5 % B to 100 % B in 2 . 4 min , hold for 
0 . 1 min , total run - time ca . 2 . 6 min . IH and 13C NMR 300 
MHz spectra were recorded on a Varian Mercury 300 BB 65 
spectrometer at room temperature . All NMR spectra were 
recorded using CDC1 , or DMSO - ds as solvents . 
NO 
6 ( 
879 / 
2 
29 
- continued NHBoc 18 :280278 US 9 , 850 , 275 B2 30 Ethyl 4 - ( 4 - acetyl - 2 - methoxy - 5 - nitrophenoxy ) butanoate 
( 1c ) . NH La NO2 
95 % 
NO , 10 
3 
NHBoc 
NH 
NO2 
OH 
Synthesis of Boc - protected hydrazine - functionalized carboxylic acid linker 4 : 
a ethyl 4 - bromobutyrate , K2CO3 , DMF , 60° C . 
b HNO3 , Ac20 
c NaBH4 , MeOH 
d SOCl2 , CH2Cl2 
e tert - Butyl carbazate , K2CO3 , KI ,DMF 
f LiOH , H , O / THF . 
A solution of ketoester 1b ( 10 . 0 g , 35 . 7 mmol ) in 30 mL 
acetic anhydride was slowly added to a solution of 70 % 
20 HNO3 ( 200 mL ) and acetic anhydride ( 40 mL ) at 0° C . After 
stirring for 3 h the reaction mixture was poured into ice 
cooled water . The precipitate was immediately collected by 
filtration ( we found that leaving the mixture for longer time 
reduced the yield due to hydrolysis of the ester ) . The 
25 precipitate was washed extensively with water before being 
dried under vacuum to afford 10 . 8 g of lc ( 82 % ) as a pale 
yellow solid . 
' H NMR ( 300 MHz , CDC1z ) : 8 = 1 . 23 ( t , J = 7 . 3 Hz , 3H ) , 
2 . 10 ( pentet , J = 7 . 3 Hz , 2H ) , 2 . 50 ( t , J = 7 . 1 Hz , 2H ) , 2 . 51 ( s , 
30 3H ) , 3 . 83 ( s , 3H ) , 4 . 03 ( t , J = 7 . 3 Hz , 2H ) , 4 . 10 ( 9 , 3 = 7 . 1 Hz , 
2H ) , 6 . 95 ( s , 1H ) , 7 . 57 ( s , 1H ) ; 13C NMR ( 75 . 5 MHz , 
CDC1 , ) : 8 = 14 . 3 , 24 . 3 , 28 . 2 , 30 . 4 , 55 . 7 , 59 . 6 , 68 . 4 , 108 . 6 , 
110 . 7 , 132 . 8 , 138 . 2 , 148 . 8 , 154 . 3 , 173 . 2 , 198 . 7 ; UPLC / MS 
5 ( ESI ) m / z 326 . 3 [ M + H ] * . Ethyl 4 - ( 4 - Acetyl - 2 - methoxyphenoxy ) butanoate ( 1b ) . 
Ethyl 4 - ( 4 - ( 1 - hydroxyethyl ) - 2 - methoxy - 5 - nitrophe 
noxy ) butanoate ( 1d ) . ' 
40 
OH 
NO2 
45 
To a solution of acetovanillone la ( 35 . 5 g , 0 . 21 mol ) in 50 
DMF ( 120 mL ) was added K2CO3 ( 44 . 3 g , 0 . 32 mol ) and 
ethyl 4 - bromobutyrate ( 31 . 0 mL , 0 . 21 mol ) . The mixture To a solution of 1c ( 4 . 00 g , 12 . 3 mmol ) in 300 mL MOH 
was stirred for 16 hours at rt , then heated for 3 hours at 50° at 0° C . was slowly added NaBH4 ( 1 . 2 g ; 31 . 7 mmol ) in 
C . After filtration the solution was partitioned between portions . After complete addition , the mixture was allowed 
EtoAc and H , O . The organic phase was washed several » to reach rt . The reaction was complete after 3 h ( as judged 
times with H , O to remove the DMF . The organic phase was by TLC ) . The reaction was quenched by addition of 200 mL 
dried ( MgSO4 ) , filtered and the solvent was removed by of sat . NH _ C1 ( aq ) . The reaction was extracted with EtOAC 
rotary evaporation to afford 58 . 9 g of 1b ( quant . ) as a white ( 400 mL ) , washed with water ( 2x300 mL ) and brine ( 300 
solid . 60mL ) . The organic phase was dried ( MgSO4 ) , filtered and the 60 
' H NMR ( 300 MHz , CDC1z ) : 8 = 1 . 23 ( t , J = 7 . 3 Hz , 3H ) , solvent was removed by rotary evaporation to give 4 . 0 g of 2 . 17 ( pentet , J = 7 . 3 Hz , 2H ) , 2 . 52 ( t , J = 7 . 3 Hz , 2H ) , 2 . 53 ( s . 1d ( quant . ) as a pale yellow solid . 
3H ) , 3 . 88 ( s , 3H ) . 3 . 87 - 4 . 17 ( m . 4H ) , 6 . 87 ( d . 3 = 8 . 4 Hz . 11 ) . " H - NMR ( 300 MHz , CDC1z ) : d = 1 . 20 ( t , J = 7 . 2 Hz , 3H ) , 
7 . 47 - 7 . 53 ( m , 2H ) ; 13C NMR ( 75 . 5 MHz , CDC1 . ) : 8 = 14 . 4 . 1 . 48 ( d , J = 7 . 0 Hz , 3H ) , 2 . 10 ( pentet , J = 7 . 0 Hz , 2H ) , 2 . 47 ( t , 
24 . 5 , 26 . 5 , 30 . 8 , 56 . 2 , 60 . 7 , 68 . 0 , 110 . 6 , 111 . 4 , 123 . 4 , 130 . 7 , 65 J = 7 . 1 Hz , 2H ) , 3 . 90 ( s , 3H ) , 4 . 03 ( t , J = 7 . 0 Hz , 2H ) , 4 . 08 ( q , 
149 . 5 , 152 . 8 , 173 . 3 , 196 . 7 ; UPLC / MS ( ESI ) m / z 281 . 3 J = 7 . 1 Hz , 2H ) , 5 . 48 ( q , J = 7 . 0 Hz , 1H ) , 7 . 23 ( s , 1H ) , 7 . 50 ( s , 
[ M + H ] * . 1H ) ; 13C NMR ( 75 . 5 MHz , CDC13 ) : 8 = 14 . 9 , 23 . 9 , 27 . 8 , 
US 9 , 850 , 275 B2 
31 32 
30 . 0 , 56 . 0 , 61 . 6 , 68 . 1 , 108 . 5 , 109 . 8 , 137 . 8 , 138 . 5 , 147 . 7 , 
153 . 8 , 174 . 6 ; UPLC / MS ( ESI ) m / z 328 . 4 [ M + H ] * , 310 . 3 
[ M - OH ] * . 
Ethyl 4 - ( 4 - ( 1 - chloroethyl ) - 2 - methoxy - 5 - nitrophe 
noxy ) butanoate ( 2 ) 
" H - NMR ( 300 MHz , DMSO - d , ) : 8 = 1 . 2 ( t , J = 7 . 1 Hz , 3H ) , 
1 . 25 ( d , 3 = 7 . 1 Hz , 3H ) , 1 . 33 ( s , 9H ) , 1 . 95 ( pentet , J = 7 . 0 Hz , 
2H ) , 2 . 44 ( t , J = 7 . 1 Hz , 2H ) , 3 . 93 ( s , 3H ) , 4 . 02 - 4 . 10 ( m , 4H ) , 
4 . 62 ( q , 3 = 7 . 0 Hz , 1H ) , 7 . 48 ( s , 1H ) , 7 . 50 ( s , 1H ) , 8 . 16 ( s , 
5 1H ) ( NHNHBoc proton not observed ) ; 13C NMR ( 75 . 5 
MHz , CDC1z ) : 8 = 13 . 7 , 20 . 5 , 23 . 6 , 27 . 7 , 29 . 6 , 53 . 1 , 55 . 4 , 
59 . 5 , 67 . 3 , 77 . 9 , 108 . 0 , 109 . 9 , 140 . 8 , 145 . 6 , 152 . 7 , 155 . 6 , 
172 . 0 ; UPLC / MS ( ESI ) m / z 442 . 2 [ MH ] + . 
HRMS ( ESI ) calculated for C23H25N20 , [ M + H ] : 
10 m / z = 442 . 2189 , found m / z = 442 . 2203 . 
NO2 
4 - ( 4 - ( 1 - ( 2 - ( tert - butoxycarbonyl ) hydrazinyl ) ethyl ) - 2 
methoxy - 5 - nitrophenoxy ) butanoic acid ( 4 ) 
NHBoc 
NH 
20 
NO2 
OH 
To a solution of 1d ( 4 . 0 g , 12 . 3 mmol ) in 60 mL CH C12 
at 0° C . was added thionyl chloride ( 20 mL ) . The reaction 
was allowed to reach rt . The reaction was complete after 2 
h ( as judged by TLC ) . The reaction was evaporated to 
dryness and co - evaporated several times with toluene ( 3x20 25 
mL ) . The residue was passed through a short plug of silica 
using EtOAc / heptane ( 1 : 1 ) as the eluent . Evaporation of the 
solvent gave 3 . 6 g of 1 ( 79 % ) as a pale yellow solid . 
" H - NMR ( 300 MHz , CDC1z ) : = 1 . 20 ( t , J = 7 . 2 Hz , 3H ) , tert - Butyl 2 - ( 1 - ( 4 - ( 4 - ethoxy - 4 - oxobutoxy ) - 5 - methoxy - 2 
1 . 80 ( d , J = 7 . 1 Hz , 3H ) , 2 . 10 ( pentet , J = 7 . 0 Hz , 2H ) , 2 . 47 ( t , 30 nitrophenyl ) ethyl ) hydrazinecarboxylate ( 2 ) ( 1 . 5 g , 3 . 4 
J = 7 . 1 Hz , 2H ) , 3 . 92 ( s , 3H ) , 4 . 03 - 4 . 13 ( m , 4H ) , 5 . 86 ( g , mmol ) was dissolved in a mixture of THF ( 30 ml ) and H2O 
J = 7 . 1 Hz , 1H ) , 7 . 23 ( s , 1H ) , 7 . 43 ( s , 1H ) : 13C NMR ( 75 . 5 ( 7 . 5 mL ) . LiOH ( 0 . 408 g , 17 . 0 mmol ) was added and the 
MHz , CDC13 ) : 8 = 14 . 5 , 24 . 4 , 27 . 6 , 30 . 8 , 54 . 0 , 56 . 6 , 60 . 8 , reaction mixture was stirred overnight . The reaction was 
68 . 5 , 108 . 7 , 110 . 6 , 133 . 0 , 140 . 0 , 147 . 8 , 154 . 0 , 173 . 1 ; UPLCI acidified ( pH = 6 ) with HCl ( 1 M , aq . ) and the reaction 
MS ( ESI ) m / z 346 . 4 [ M + H ] * , 310 . 3 [ M - Cl ] + . 35 extracted with EtOAC ( 2x100 ml ) and the organic phase was washed with water ( 3x150 mL ) and brine ( 150 ml ) , dried 
tert - butyl 2 - ( 1 - ( 4 - ( 4 - ethoxy - 4 - oxobutoxy ) - 5 over anhydrous Na2SO4 and concentrated in vacuo to give 1 . 3 g of 4 ( 95 % ) as a yellow solid . methoxy - 2 - nitrophenyl ) ethyl ) hydrazinecarboxylate H - NMR ( 300 MHz , DMSO - d ) : 8 = 1 . 21 ( d , J = 7 . 1 Hz , ( 3 ) 40 3H ) , 1 . 33 ( s , 9H ) , 1 . 95 ( pentet , J = 7 . 0 Hz , 2H ) , 2 . 39 ( t , J = 7 . 1 
Hz , 2H ) , 3 . 93 ( s , 3H ) , 4 . 20 ( t , 2H ) , 4 . 60 ( 9 , J = 7 . 0 Hz , 1H ) , 
7 . 48 ( s , 1H ) , 7 . 50 ( s , 1H ) , 8 . 16 ( s , 1H ) , 11 . 90 ( bs , 1H ) ( NHNHBoc proton not observed ) ; UPLC / MS ( ESI ) m / z 
414 . 2 [ MH ] + . 
?? 45 HRMS ( ESI ) calculated for C23H25N20 , [ M + H ] : 
m / z = 414 . 1876 , found m / z = 414 . 1902 . 
NHBoc 
NO2 Example 2 
50 Solid - Phase Synthesis 
Attachment of Boc - Protected Hydrazine - Linker ( 4 ) to 
Amino - Functionalized PEGAeon Beads 
Boc - protected hydrazine - functionalized carboxylic acid 
linker ( 4 ) was dissolved in DMF , and NEM ( 4 equiv . ) 
55 followed by TBTU ( 2 . 88 equiv . ) were added . The mixture Ethyl 4 - ( 4 - ( 1 - chloroethyl ) - 2 - methoxy - 5 - nitrophenoxy ) was shaken for 5 min at room temperature before being 
butanoate ( 2 ) ( 1 . 49 g , 4 . 34 mmol ) and Boc - carbazate ( 1 . 4 g , added to amino - functionalized PEGAgoo beads pre - swelled 
5 . 4 mmol ) were dissolved in DMF ( 16 ml ) and K COZ ( 0 . 6 in DMF . The mixture was shaken for 2 h at room tempera 
g , 4 . 34 mmol ) followed by KI ( 0 . 033 g , 0 . 2 mmol were ture , followed by washing with DMF ( x6 ) , MeOH ( x6 ) and 
added . The reaction mixture was heated to 60° C . for 12 60 CH , C1 , ( x6 ) before being lyophilized . 
hours . The reaction was cooled to rt and water was added General Procedure for Removal of Hydrazine Boc Pro 
( 100 ml ). The mixture was extracted with EtoAc ( 200 ml ) tecting Group 
and the organic phase was washed with water ( 3x150 mL ) Boc deprotection was carried in a 2 mL plastic syringe 
and brine ( 150 ml ) , dried over anhydrous Na , So , and fitted with a rubber septum . The Boc - protected hydrazine 
concentrated in vacuo . The residue was purified by column 65 functionalized resin was swelled in CH2Cl2 and 2 , 6 - lutidine 
chromatography ( SiO2 , 20 - 50 % EtoAc in heptane ) to yield ( 1 . 5 M ) followed by TMSOTf ( 1M ) added . The mixture was 
1 . 7 g of 3 ( 87 % ) as a yellow solid . shaken for 15 min followed by washing of the support twice 
US 9 , 850 , 275 B2 
33 34 
( S ) - N - ( 1 - ( ( 2 - hydrazinyl - 2 - oxoethyl ) amino ) - 1 - oxo 
3 - phenylpropan - 2 - yl ) - 2 - naphthamide ( 9a ) 
10 
NH NH 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) - NH 
HN - NH 15 
NO , 
with CH2Cl2 . The deprotection procedure was repeated 
twice . After the last deprotection cycle , the support was 
washed with washed with CH C12 ( x6 ) , DMF ( x6 ) and used 
directly in the next coupling reaction or washed further with 
MeOH ( x6 ) and CH C1 , ( x6 ) before being lyophilized . 5 
General Procedure for TBTU - Mediated Coupling of 
Fmoc - Protected Amino Acids to Hydrazine - or Amino 
Functionalized PEGA300 Beads ( Synthesis of 7 10a - m ) 
The corresponding Fmoc - protected amino acid ( 3 equiv . ) 
was dissolved in DMF , and NEM ( 4 equiv . ) followed by 
TBTU ( 2 . 88 equiv . ) were added . The mixture was shaken for 
5 min at room temperature before being added to hydrazine 
or amino - functionalized PEGA300 beads pre - swelled in 
DMF . The mixture was shaken for 2 h at room temperature , 
followed by washing with DMF ( x6 ) . 
Removal of the Fmoc protecting group was accomplished 20 
with 20 % piperidine in DMF for 5 min . After washing twice 
with DMF , the deprotection procedure was repeated , now 
with a reaction time of 30 min . The support was washed with 
DMF ( x6 ) , MeOH ( x6 ) and CH2Cl2 ( x6 ) before being 25 
lyophilized . 
General Procedure for TBTU - Mediated Coupling of Boc 
Protected Amino Acids to Hydrazine - or Amino - Function 
alized PEGA300 Beads ( Synthesis of 10a - m ) 
The corresponding Boc - protected amino acid ( 3 equiv . ) ( 3 
equiv . ) was dissolved in DMF , and NEM ( 4 equiv . ) followed 
by TBTU ( 2 . 88 equiv . ) were added . The mixture was shaken 
for 5 min at room temperature before being added to 35 
hydrazine - or amino - functionalized PEGA800 beads pre 
swelled in DMF . The mixture was shaken for 2 h at room 
temperature . The support was washed with DMF ( x6 ) , 
MeOH ( x6 ) and CH C12 ( x6 ) . 
Removal of the Boc protecting group was accomplished 
with 50 % TFA in CH , C1 , for 30 min . The support was 
washed with CH , C12 ( x6 ) and DMF ( x6 ) and used directly 
in the next coupling step or washed further with MeOH ( 6 ) 
and CH , C1 , ( x6 ) before being lyophilized . 
– NH 
aqueous 
buffer 
( pH = 6 ) NH 
— NH 
40 
NH NH 
45 
HN - NH 
9? 
ya 
50 
Example 3 
55 
- NH ?? 
Procedure for Release of Compounds from Photo - Labile 
Linker for Analytical Purposes 
Resin sample ( 5 - 50 mg ) was immersed in CH2CN / ac 
etone ( 1 : 4 , 0 . 5 - 5 mL ) in 1 - 10 mL Petri dishes with an opened 
top and irradiated from the top with a LED UV - lamp 400W 
for 2 h . The beads were filtered and washed with CH , CN . 60 
The solvent was removed in vacuo and the crude products 
used directly for analytically purposes ( the acetone hydra 
zones were usually not or only partly observed in HPLC and 
LCMS experiments due to the acidity of the eluent ) . How 
ever , NMR experiments confirmed the release of hydrazides 
fully protected as their corresponding acetone hydrazones . 
HN NH 
UPLC : Rt = 1 . 41 ( 1 . 64 corresponds to acetone hydrazone 
UPLC - MS ( ESI ) calculated for C , H , NO , FM + H ] " : 
m / z = 407 . 2 , found m / z = 407 . 4 . 
US 9 , 850 , 275 B2 
35 36 36 os termos assage ( S ) N - ( 1 - hydrazinyl - 1 - oxopropan - 2 - yl ) - 2 - naphth amide ( 9b ) 
antes HN - NH HN - NH / ( NO2 hv , CH3CN acetone ( 1 : 4 ) ? ?? N 
N - NH 
aqueous 
buffer ( pH = 6 ) HN - NH TEL . 
9b 
HN - NH 
HN 
65 UPLC : Rt = 1 . 41 ( 1 . 64 corresponds to acetone hydrazone UPLC - MS ( ESI ) calculated for C14H 6N202 [ M + H ] : 
m / z = 258 . 1 , found m / z = 258 . 3 . 8a ) 
US 9 , 850 , 275 B2 
37 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 1 - hydrazinyl - 3 - methyl - 1 
oxobutan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) 
carbamate ( 90 ) 
38 
- continued 
YX in 
11111NH 
10 a > 111NH 
NH 
hv , 
CH3CN 
acetone 
( 1 : 4 ) 
HINA HN - NH 
9c 15 FO Oy HN - NH 96 
20 
IIIINH 
25 
villINH aqueous 
buffer 
( pH = 6 ) 
FO 
HN - NH 30 111111 
UPLC : Rt = 1 . 41 ( 1 . 64 corresponds to acetone hydrazone 
N - NH 8a ) 35 UPLC - MS ( ESI ) calculated for C23H22N403 [ M + H ] " : 
m / z = 407 . 2 , found m / z = 407 . 4 . 
( S ) - tert - butyl 2 - ( ( ( S ) - 1 - ( ( ( S ) - 1 - hydrazinyl - 4 - methyl 
1 - oxopentan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpropan - 2 
yl ) carbamoyl ) pyrrolidine - 1 - carboxylate ( 90 ) 
hv , 
11111NH CH3CN / 
acetone 
( 1 : 4 ) 2 ?? NH 
HN - NH 
NO2 
7d 
US 9 , 850 , 275 B2 
- continued 
aqueous 
buffer 
( pH = 6 ) } INH 
ANH 
NH 
?? 
N - NH 
H?N _ NH 
9d 9d 
8d 
9d 
11111NH 
NH 
HN _ NH 
35 
UPLC : Rt = 1 . 58 ( 1 . 81 corresponds to acetone hydrazone 
8d ) 
UPLC - MS ( ESI ) calculated for C25H40N , 05 [ M + H ] " : 
m / z = 490 . 3 , found m / z = 490 . 3 . 
N — ( ( S ) - 1 - ( ( ( R ) - 1 - hydrazinyl - 4 - methyl - 1 - oxopen 
tan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) - 2 
naphthamide ( 90 ) 
hv , 
HN - NH ) HN 
CH3CN / 
acetone 
( 1 : 4 ) HN - NH 
NO2 
- NH 
0 
N – NH ) aqueous buffer 
( pH = 6 ) buffers 
HNNH H2N - NH HN 
HN y HN y 
US 9 , 850 , 275 B2 
41 
- continued 
9e 
HN _ NH ) 
HN 
UPLC : Rt = 1 . 73 ( 2 . 01 corresponds to acetone hydrazone 
8e ) 
UPLC - MS ( ESI ) calculated for C26H31N403 [ M + H ] " : 
m / z = 447 . 2 , found m / z = 447 . 2 . 
tert - butyl ( ( S ) - 1 - ( ( ( R ) - 1 - ( ( ( 2S , 3S ) - 1 - hydrazinyl - 3 
methyl - 1 - oxopentan - 2 - yl ) amino ) - 1 - oxopropan - 2 - yl ) 
amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) carbamate ( 9h ) 
0 = 
hv , NH NH CH3CN / 
acetone 
( 1 : 4 ) NH 
HN - NH 
NO2 
7h 
O = 
< NH NH 
HN 
aqueous 
buffer ( pH = 6 ) NH NH per HN N _ NH H2N - NH 
9h 
US 9 , 850 , 275 B2 
43 44 
UPLC : Rt = 1 . 50 , 1 . 74 ( corresponds to acetone hydrazone 
8h ) 9h 
UPLC - MS ( ESI ) calculated for C23H36N305 [ M + H ] " : 
m / z = 464 . 3 , found m / z = 464 . 4 . 
NH NH 
HN HN 10 
HN - NH . 
15 
tert - butyl ( ( S ) - 1 - ( ( ( R ) - 1 - ( ( ( S ) - 1 - hydrazinyl - 4 - ( meth 
ylthio ) - 1 - oxobutan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpro 
pan - 2 - yl ) amino ) - 4 - methyl - 1 - oxopentan - 2 - yl ) car 
bamate ( 9 ) 
hv , 03 
< NH NH CH?CN / 
acetone 
( 1 : 4 ) 
NH 
HN _ NH 
NO2 
0 = 
NH 
aqueous 
buffer 
( pH = 6 ) . NH ANH 
HN 
HN 
. 
N - NH 
FO 
HN - NH 
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- continued 
NH 
HN 
FO 
HN - NH 
- continued 
20 
UPLC : Rt = 1 . 58 ( 1 . 81 corresponds to acetone hydrazone 
8i ) 
UPLC - MS ( ESI ) calculated for C25H42N O - S [ M + H ] " : 
m / z = 524 . 3 , found m / z = 524 . 3 . 
25 25 ( S ) - N - ( 1 - oxo - 3 - phenyl - 1 - ( 2 - ( propan - 2 - ylidene ) 
hydrazinyl ) propan - 2 - yl ) - 2 - naphthamide ( 9j ) 
HN 
30 
H2N NH 
9 
35 35 hv , 
HN OyZ , CH3CN / acetone ( 1 : 4 ) HN - NH 
$ 
a s
cuot HNL 
aqueous 
buffer ( pH = 6 ) HN - NH 
HNE 
2 
UPLC : Rt = 1 . 47 , 1 . 71 ( corresponds to acetone hydrazone 8j ) N - NH 
65 
DO UPLC - MS ( ESI ) calculated for C20H2 . N302 [ M + H ] " : 
m / z = 334 . 2 , found m / z = 334 . 3 . 
48 
US 9 , 850 , 275 B2 
47 
N — ( ( S ) - 1 - ( ( ( S ) - 1 - hydrazinyl - 1 - oxo - 3 - phenylpro 
pan - 2 - yl ) amino ) - 4 - methyl - 1 - oxopentan - 2 - yl ) - 2 
naphthamide ( 9k ) 
- continued 
Ful [ NH 
y 10 
FO 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
HN 11NH 
NH HN H?N - NH 
FO 
HN - NH 
Ok 
30 
vui [ NH 
HN 
aqueous 
buffer ( pH = 6 ) 
luINH 35 HN - NH 
UPLC : Rt = 1 . 74 . 198 ( corresponds to acetone hydrazone 
N _ NH 40 8k ) 
UPLC - MS ( ESI ) calculated for C26H31N403 [ M + H ] : 
m / z = 447 . 2 , found m / z = 447 . 3 . 
sk tert - butyl ( ( S ) - 1 - ( ( S ) - 2 - ( hydrazinecarbonyl ) pyrroli 
din - 1 - yl ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) carbamate ( 91 ) 
NH 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
HN - NH 1NNE eins NO2 NH 
71 
US 9 , 850 , 275 B2 
? 4 50 
- continued 
* NH NH 
aqueous 
buffer ( pH = 6 
N - NH HN - NH ?? 
81 
/ NH 
HN - NH . 
40 ) 
UPLC : Rt = 1 . 74 . 198 ( corresponds to acetone hydraZone 
81 ) 
UPLC - MS ( ESI ) calculated for C6H1N40 [ M + H ] : 
m / z = 377 . 2 , found m / z = 377 . 3 . 
N ( ( S ) - 1 - ( ( S ) - 2 - ( hydrazinecarbonyl ) pyrrolidin - 1 
y1 ) - 1 - oxO - 3 - phenylpropan - 2 - y1 ) - 2 - naphthamide ( 9m ) 
NH 
hv , 
CH3CN / 
acetone 
( 14 ) 
HN - NH 
- NH 
m 
US 9 , 850 , 275 B2 
51 52 
- continued 
NH NH 
aqueous 
buffer ( pH = 6 ) 
N - NH HN _ NH 
8m 9m 
Om 
NH 
HN - NH 
35 
UPLC : Rt = 1 . 50 , 1 . 77 ( corresponds to acetone hydrazone 
8m ) ÚPLC - MS ( ESI ) calculated for C25H24N403 [ M + H ] " : 
m / z = 431 . 2 , found m / z = 431 . 3 . 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 1 - ( ( ( S ) - 3 - ( 4 - ( tert - butoxy ) phe 
nyl ) - 1 - hydrazinyl - 1 - oxopropan - 2 - yl ) amino ) - 4 
methyl - 1 - oxopentan - 2 - yl ) amino ) - 1 - oxo - 3 - phenyl 
propan - 2 - yl ) carbamate , BocPhe - Leu - Tyr ( tBu ) 
NHNH2 ( 90 ) 
40 
HNE 
HN 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
HN 
NH 
HN - NH 
US 9 , 850 , 275 B2 
54 
- continued 
IV 
HN 
HN aqueous 
buffer 
( pH = 6 ) - to 
0 HN 
" 
N - NH 
HN - NH 
90 
90 
HNE 
V 
HN 
, 
HN _ NH 
UPLC : Rt = 2 . 07 , 2 . 26 ( corresponds to acetone hydrazone 
80 ) 
UPLC - MS ( ESI ) calculated for C33H50N306 [ M + H ] " : 
m / z = 612 . 4 , found m / z = 612 . 4 . 
65 
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SS 56 ??? tert - buryl ( ( S ) - 1 - ( ( ( R ) - 1 - ( ( ( S ) - 1 - hydrazinyl - 3 - ( 1H indol - 3 - yl ) - 1 - OXOpropan - 2 - ylamino ) - 1 - oxopropan 2 - y1 ) amino ) - 1 - OXO - 3 - phenylpropan - 2 - yl ) carbamate , Boc - Phe - Ala - Trp - NHNH , ( 9q ) 
NH NH 
HN 
hy , 
CH3CN / 
acetone 
( 1²4 ) NH 
HN - NH 
NO ? 
7q . 
ANH NH aqueous buffer 
( pH = 6 ) NH ?????? NH HN IN 1 = NH - = = 0 N - NH HN - NH 
94 
< TNH NH 
HN 
HN - NH 
65 
UPLC : Rt = 2 . 07 , 2 . 26 ( corresponds to acetone hydrazone 
8q ) 
- UPLC - MS ( ESI ) calculated for CHNO , [ M + H ] : 
m / z = 537 . 3 , found m / z = 537 . 3 . 
US 9 , 850 , 275 B2 
57 58 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 3 - ( benzyloxy ) - 1 - hydrazinyl - 1 
oxopropan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) 
carbamate , BocPhe - Ser ( Bzl ) - NHNH2 ( 9 ) 
HN 
NH 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
HN - NH 
NO2 
NH ei 
HN HN 
VH 
aqueous 
buffer 
( pH = 6 ) NH 
N _ NH HN - NH 
9r 45 
HN 
50 
55 
H2N - NH 
60 
UPLC : Rt = 1 . 72 , 2 . 01 ( corresponds to acetone hydrazone 
8r ) 
UPLC - MS ( ESI ) calculated for C24H33N403 [ M + H ] " : 
m / z = 457 . 3 , found m / z = 457 . 3 . 
65 
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N ( ( S ) - 1 - ( ( ( S ) - 3 - benzyloxy ) - 1 - hydrazinyl - 1 - oxo 
propan - 2 - yl ) amino ) - 1 - OXO - 3 - phenylpropan - 2 - y1 ) - 2 
naphthamide , Naph - Phe - Ser ( Bzl ) - NHNHg ( 9s ) 
HN 
hy , 
NH CH3CN / 
acetone 
( 14 ) 
HN - NH ??? NO NH 
< < 
HN HN 
NH 
aqueous 
buffer 
( pH = 6 ) 
NH 
N - NH HN - NH 
Os 8s 
US 9 , 850 , 275 B2 
62 
HN 
H2N - NH 
UPLC : Rt = 1 . 82 , 2 . 03 ( corresponds to acetone hydrazone 25 
8s ) 
HI : 30 UPLC - MS ( ESI ) calculated for C30H31N404 [ M + H ] : 
m / z = 511 . 1 , found m / z = 511 . 3 . 
35 tert - butyl ( ( S ) - 1 - ( ( ( S ) - 1 - ( ( ( 2S , 3R ) - 3 - ( tert - butoxy ) - 1 - 
hydrazinyl - 1 - oxobutan - 2 - yl ) amino ) - 4 - methyl - 1 
oxopentan - 2 - yl ) amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) 
carbamate , BocPhe - Leu - Thr ( tBu ) - NHNH , ( 9t ) 
HN 
NH 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
HN - NH 
NO2 
74 
US 9 , 850 , 275 B2 
63 64 03 - continued continued 
de HN HN 
HN W aqueous buffer 
( pH = 6 ) 
NH zoo NH 
N _ NH . 
HN - NH 
f . 
30 
9t 35 
HN 40 
HN 
45 
NH 
HN - NH 
50 
55 
60 
UPLC : Rt = 1 . 92 , 2 . 18 ( corresponds to acetone hydrazone 
8t ) 
05 
UPLC - MS ( ESI ) calculated for C28H43N , 06 [ M + H ] : 
m / z = 550 . 4 , found m / z = 550 . 4 . 
66 
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65 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 3 - ( 4 - ( tert - butoxy ) phenyl ) - 1 ( ( ( S ) - 1 - hydrazinyl - 1 , 4 - dioxo - 4 - ( tritylamino ) butan - 2 
yl ) amino ) - 1 - oxopropan - 2 - yl ) amino ) - 1 - oxopropan - 2 
yl ) carbamate , Boc - Ala - Tyr ( tBu ) - Asn ( Trt ) - NHNH2 
( 9u ) 
HN 
HN 
HN 
HN - NH 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
- ?? 
7u 
HN 
HN 
net HN HN aqueous buffer ( pH = 6 ) N _ NH 
Su 
HN ge HN HN 
HN - NH 
9u 
US 9 , 850 , 275 B2 
68 
Su 
HN 
HN 
HN 
HN - NH 
UPLC : Rt = 2 . 32 , 2 . 47 ( corresponds to acetone hydrazone 
8u ) 25 
UPLC - MS ( ESI ) calculated for C44H55NGO , [ M + H ] : 20 
m / z = 779 . 4 , found m / z = 779 . 5 tert - butyl ( ( R ) - 1 - ( ( ( R ) - 1 ( ( ( R ) - 1 - hydrazinyl - 1 , 5 - dioxo - 5 - ( tritylamino ) pentan - 2 - yl ) 
amino ) - 1 - oxo - 3 - phenylpropan - 2 - yl ) amino ) - 4 - methyl - 1 
oxopentan - 2 - yl ) carbamate , Boc - Leu - Phe - Gln ( Trt ) - NHNH , 
NH HN 
hv , 
NH 
omato CH3CN / acetone ( 1 : 4 ) HN - NH NH 
US 9 , 850 , 275 B2 
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- continued 
NH HN 
NH HN 
aqueous 
buffer ( pH = 6 ) H5N - NH 
N - NH 
- NH 
- NH 
8v 
9v 
NH HN 
NH 
H2N - NH 
NH 
UPLC : Rt = 2 . 31 , 2 . 46 ( corresponds to acetone hydrazone 60 
8v ) 
65 UPLC - MS ( ESI ) calculated for C44H55N606 [ M + H ] " : 
m / z = 763 . 4 , found m / z = 763 . 5 . 
US 9 , 850 , 275 B2 
71 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 1 - ( ( ( R ) - 3 - ( tert - butyldisulfa 
nyl ) - 1 - hydrazinyl - 1 - oxopropan - 2 - yl ) amino ) - 4 
methyl - 1 - oxopentan - 2 - yl ) amino ) - 1 - oxo - 3 - phenyl 
propan - 2 - yl ) carbamate , BocPhe - Leu - Cys ( tBu ) 
NHNH2 ( 9w ) 
HN 
HN 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) 
NH NH 
HN _ NH . 
NO2 
7w 
HN HN 
aqueous 
buffer 
( pH = 6 ) 
NH 
N _ NH HN - NH 
8w 9w 
US 9 , 850 , 275 B2 
73 74 
9w 
HN 
NH 
H2N - NH 
UPLC : Rt = 2 . 07 , 2 . 28 ( corresponds to acetone hydrazone 
8w ) 
25 
UPLC - MS ( ESI ) calculated for C27H46N 0 S2 [ M + H ] " : 
m / z = 584 . 3 , found m / z = 584 . 3 . 
30 
tert - butyl ( ( S ) - 1 - ( ( ( S ) - 3 - ( 4 - tert - butoxy ) phenyl ) - 1 ( ( ( S ) - 1 - hydrazinyl - 1 - oxo - 5 - ( 3 - ( ( 2 , 2 , 4 , 6 , 7 - pentam 
ethyl - 2 , 3 - dihydrobenzofuran - 5 - yl ) sulfonyl ) guani 
dino ) pentan - 2 - yl ) amino ) - 1 - oxopropan - 2 - yl ) amino ) 
1 - oxopropan - 2 - yl ) carbamate , Boc - Ala - Tyr ( tBu ) - Arg 
( Pbf ) - NHNH , ( 9x ) 
HN 
o =n0S — NH - NH 
NH 
HN HN 
hv , omg - NH 13181 CH3CN / acetone ( 1 : 4 ) HN - NH 
NO2 
US 9 , 850 , 275 B2 
75 
- continued 
0 
HNE 
string a o =n0- s — NH - NH ?? HN HN aqueous buffer ( pH = 6 ) | N – NH 
8x 
HN 
= 
SNH NH NH 
= 
NH 
I HN H  
= O 
H2N - NH 
O HN patentino = NH = NH O FO 
HN - NH 
UPLC : Rt = 2 . 01 , 2 . 16 ( corresponds to acetone hydrazone 
8x ) 
UPLC - MS ( ESI ) calculated for C40H63N , O , S [ M + H ] " : 
m / z = 831 . 4 , found m / z = 831 . 5 . 
65 
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tert - butyl 4 - ( ( 6R , 9R , 12R ) - 9 - benzyl - 12 - ( hydrazin 
ecarbonyl ) - 6 - isopropyl - 2 , 2 - dimethyl - 4 , 7 , 10 - trioxo 
3 - oxa - 5 , 8 , 11 - triazatridecan - 13 - yl ) - 1H - imidazole - 1 
carboxylate ; BocVal - Phe - His ( Boc ) - NHNH , ( 9y ) * * * 
NH HN 
HN 
hv , 
CH3CN / 
acetone 
( 1 : 4 ) NH 
FO 
HN _ NH 
NO2 
NH HN 
NH HN ( aqueous buffer ( pH = 6 ) HN . buffer HN 
HN - NH 
N _ NH 
9y45 
( S ) - N - ( 1 - hydrazinyl - 3 - ( 1H - imidazol - 4 - yl ) - 1 - oxo 
propan - 2 - yl ) - 2 - naphthamide ; Naph - His - NHNH2 
( 92 ) 
50 
NH NH HN HN . 
HN 
55 
FO 
HN _ NH hv , IN N 1 HN 
CH3CN / 
acetone 
( 1 : 4 ) 
UPLC : Rt = 1 . 76 , 1 . 93 ( corresponds to acetone hydrazone of Ova l 60 HN - NH 
7z 05 
UPLC - MS ( ESI ) calculated for C30H46N , 02 [ M + H ] : 
m / z = 616 . 4 , found m / z = 616 . 5 . 
79 
- continued 
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80 
( S ) - tert - butyl ( 5 - ( 2 - naphthamido ) - 6 - hydrazinyl - 6 
oxohexyl ) carbamate ; Napht - Lys ( Boc ) - NHNH , ( 9aa ) 
hv , aqueous buffer 
( pH = 6 ) 
HN 
HN CH3CN / 
acetone 
( 1 : 4 ) 
- NH 
ZY HN - NH N _ NH 
??? po to ,8z 
aqueous 
buffer 
( pH = 6 ) 
HN 
HN 
N - NH 
çok üzüHN HN 8aa 
HN - NH 
92 
HN 
IN 
O 
HN _ NH 
9aa 
Oz 
9aa 
sü çok HN HN 
HN 
HN - NH 
H2N - NH 
UPLC : Rt = 0 . 75 UPLC : Rt = 1 . 55 , 1 . 49 ( corresponds to acetone hydrazone 
65 Saa ) 
UPLC - MS ( ESI ) calculated for C7H18N , 02 [ M + H ] : UPLC - MS ( ESI ) calculated for C22Hz , N404 [ M + H ] " : 
m / z = 324 . 2 , found m / z = 324 . 2 . m / z = 415 . 2 , found m / z = 415 . 2 . 
US 9 , 850 , 275 B2 
Bocoalele de 81 BocAla - Phe - Lys ( Boc ) - NHNH ( 9ab ) Man US 9 ,850 , 275 B2 82 
I 
hv , 
- NH HN onarte acetone / CH3CN ( 4 : 1 ) HN - NH HN NO2 NH 
7ab 
HNE HND 
aqueous 
buffer 
( pH = 6 ) 
and gek HN N – NH HN H2N - NH HN gerek NH NH 
8ab 9ab 
US 9 , 850 , 275 B2 
83 84 
9ab 
HN 
HN 
HN - NH HN 
NH 
25 
UPLC : Rt = 1 . 63 , 1 . 83 ( corresponds to acetone hydrazone 
Sab ) 
UPLC - MS ( ESI ) calculated for C28H4 - N . 0 , [ M + H ] " : 
m / z = 579 . 4 , found m / z = 579 . 4 . 
30 30 ( S ) - tert - butyl 3 - ( ( R ) - 2 - ( ( tert - butoxycarbonyl ) amino ) - 3 - phenylpropanamido ) - 4 - hydrazinyl - 4 
oxobutanoate ; Boc - Phe - Asp ( tBu ) - NHNH2 ( 9ac ) 
NH hv , 
HN CH3CN / 
acetone 
( 1 : 4 ) - NH 
HN - NH 
NO2 
7 ac 
te frya tetty INH NH HN HN " aqueous buffer ( pH = 6 ) V 
N - NH 
HN - NH i ??? 
8ac 
US 9 , 850 , 275 B2 
85 86 
9ac 
NH 
HN 
HN - NH 
UPLC : Rt = 1 . 63 , 1 . 83 ( corresponds to acetone hydrazone 
Sac ) 
25 
UPLC - MS ( ESI ) calculated for C22H35N _ 06 [ M + H ] " : 
m / z = 451 . 3 , found m / z = 451 . 3 . 
30 
35 35 
( S ) - tert - butyl 2 - ( ( ( S ) - 1 - ( ( ( S ) - 5 - tert - butoxy ) - 1 - hy 
drazinyl - 1 , 5 - dioxopentan - 2 - yl ) amino ) - 1 - oxo - 3 - phe 
nylpropan - 2 - yl ) carbamoyl ) pyrrolidine - 1 - carboxy 
late ; BocPro - Phe - Glu ( tBu ) - NHNH2 ( 9ad ) 
o 
- NH 11111NH 
0 = 
hv , 
acetone / 
CH3CN 
( 4 : 1 ) HN _ NH NH 
NO2 
. 7ad 
US 9 , 850 , 275 B2 
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- continued 
* 100K 
> I | INH a de 
11111NH 
O = 
N – NH NH Then H2O , HN - NH NH 
8ad 
gad 
25 
gad 
NH2 
30 
HYN Y Y Ñ IIINH NH2 
07 
HN - NH NH 
40 
Starting from hydrazine - functionalized ChemMatrix resin 
6 , the linear assembly was performed following the Fmoc 
strategy according to the general procedure presented above . 
UPLC : Rt = 1 . 76 , 1 . 98 ( corresponds to acetone hydrazone 50 
Sad ) O = S = 0 
NH HN UPLC - MS ( ESI ) calculated for C28H44N30 , [ M + H ] " : 
m / z = 562 . 7 , found m / z = 562 . 5 . NH 
| HNO HN Example 4 
Synthesis of H - Cys - Lys - Tyr - Met - His - OH ( SEQ ID NO : ° 
4 ) ( 14 ) 
Starting from an HMBA - functionalized ChemMatrix 
resin , the linear assembly was performed following the 65 
Fmoc - strategy according to the general procedure presented 
above . 
US 9 , 850 , 275 B2 
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Example 5 Ligation with Cysteine : 
H - Leu - Tyr - Arg - Ala - Tyr - NHNH , ( SEQ ID NO : 2 ) ( 13 ) 
Ligation Experiments ( 1 . 73 mg , 2 . 48 umol ) and H - Cys - OH ( 0 . 40 mg , 3 . 30 umol ) 
Starting from hydrazine - functionalized Chem Matrix resin 5 were dissolved in 0 . 82 mL of ligation buffer containing 58 
uL internal standard buffers . The reaction mixture was held 6 , the linear assembly of hydrazide - ligation peptide H - Leu in a 5 mL glass vial at - 10° C . ( ice - salt bath ) . Then , 81 uL 
Tyr - Arg - Ala - Tyr - NHNH , ( SEQ ID NO : 2 ) ( 13 ) was per - of NaNO2C ( 200 mM ) was added dropwise , and the reaction 
formed following the Fmoc - strategy according to the gen mixture was stirred for 20 min at - 10° C . After that , 0 . 81 mL 
eral procedure presented above . Resin sample ( 50 mg ) was 10 of MPAA ( 200 mM ) was added , and the acidity of the 
immersed in acetone ( 2 mL ) in a 2 . 5 mL Petri dish with a mixed solution was adjusted to pH 7 . 0 with NaOH ( 2 . 0 M ) 
quartz lid and irradiated from the top with a LED UV - lamp slowly . The reaction mixture was stirred at room tempera 
400W for 2 h . The beads were filtered and washed with ture overnight . The reaction was monitored by HPLC , and 
acetone . The solvent was removed with a steam of nitrogen 13 the ligation yield was determined according to the internal 
and the crude products used directly for ligation experi standard , BzNH2 . Before analysis , the reaction solution was 
reduced by TCEP ( 30 mM , pH 7 . 0 ) . ments . [ a ] The ligation buffer : 6 . 0 M Gn . HCI , 0 . 2 M Na2HPO4 , and the acidity was 
adjusted to pH 3 . 0 with NaOH ( 2 . 0 M ) or concentrated HCl slowly . [ b ] In 
20 ternal standard buffer : 9 . 9 mg BzNH2 , 2 . 0 mL ligation buffer , pH 7 . 0 . 
HPLC of crude H - Leu - Tyr - Arg - Ala - Tyr - NHNH , ( SEQ [ c ] Oxidative solution : NaNO2 ( 41 . 4 mg , 0 . 6 mmol ) in neat water ( 3 . 0 mL ) . [ d ] The solution of RSH : MPAA ( 33 . 6 mg , 0 . 2 mmol ) in neutral ligation buffer ID NO : 2 ) ( 13 ) ( 1 mL ) . 
HN NHA 
NH OH 
NaNO2 , 
pH = 3 
NH2 11111Z 
Z 
NH 
JIU 
“ ?? 
HNN NH2 
NH LOH 
LIN 
III 
OH 
13a 
MPAA , 
pH = 7 
US 9 , 850 , 275 B2 92 
- continued ?? 
HNNH2 
SH 
OH NH OH 
HN 
T 
0 
HSY OH S OH 
NH NH OH 
NH  0 
LOH NH - NH 
NH2 ? OH OH NH2 HN  13b 
16 
H - Leu - Tyr - Arg - Ala - Tyr - NHNH2 ( SEQ ID NO : 2 ) ( 13 ) The reaction mixture was stirred at room temperature over ( 1 . 80 mg , 2 . 58 umol ) and H - Cys - Lys - Tyr - Met - His - OH night . The reaction was monitored by HPLC , and the liga 
( SEQ ID NO : 4 ) ( 14 ) ( 2 . 34 mg , 3 . 43 umol ) were dissolved tion yield was determined according to the internal standard , in 0 . 85 mL of ligation buffer containing 60 uL internal 20 BzNH2 . Before analysis , the reaction solution was reduced 
standard buffer . The reaction mixture was held in a 5 mL by TCEP ( 30 mM , pH 7 . 0 ) . 
glass vial at - 10° C . ( ice - salt bath ) . Then , 84 UL OI NaNO2 [ a ] The ligation buffer : 6 . 0 M Gn . HC1 , 0 . 2 M Na HPO4 , and the acidity was ( 200 mM ) was added dropwise , and the reaction mixture adjusted to pH 3 . 0 with NaOH ( 2 . 0 M ) or concentrated HCI slowly . [ b ] In 
was stirred for 20 min at - 10° C . After that . 0 . 84 mL of ternal standard buffer : 9 . 9 mg BzNH2 , 2 . 0 mL ligation buffer , pH 7 . 0 . 25 . [ c ] Oxidative solution : NaNO2 ( 41 . 4 mg , 0 . 6 mmol ) in neat water ( 3 . 0 mL ) . MPAA ( 200 mM ) d was added , and the acidity of the mixed 25 [ d ] The solution of RSH : MPAA ( 33 . 6 mg , 0 . 2 mmol ) in neutral ligation buffer 
solution was adjusted to pH 7 . 0 with NaOH ( 2 . 0 M ) slowly . ( 1 mL ) 
HNNH 
NH LOH 
NH2 NaNO2 , pH = 3 TI 
NH2 NH INTUI NH 
~ ?? 
13 
HNNH 
NH LOH 
: CZ 
NH 
= IITTI 
?? 
13a 
MPAA , 
pH = 7 
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- continued 
NH2 
HN NH2 
NH OH 
HS HS Y 
NH2 INH 
OH 
14 LOH 
Y LOH ?? 
13b 
?? 
NH2 
SH 
OH 
HN 
– NH HN 
- NHO - H NH 
HNL . .
HN 
NH NH 
– NH NH ? U NH2 
it . 
NH2 HN 
OH 
NH 
15 
40 
UPLC - MS ( ESI ) calculated for C62H , , N1601492 [ M + H ] : 
m / z = 1348 . 6 , found m / z = 1348 . 2 . 
Example 6 
UPLC : Rt = 1 . 82 , 1 . 90 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C23H23N40 , [ M + H ] : 
m / z = 387 . 2 , found m / z = 387 . 5 . 
Oles 45 Crude RP - HPLC and LC - MS Data for Pyranopyrazo
( 12a - 12h ) 
6 - amino - 3 - benzyl - 4 - ( 4 - methoxy - 2 , 3 - dimethylphe 
nyl ) - 1 , 4 - dihydropyrano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile 
( 12a ) 
6 - amino - 3 - benzyl - 4 - ( 3 - chlorophenyl ) - 1 , 4 - dihydro 
pyrano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile ( 12b ) 
50 
55 
60 
IZ O NH2 
IZ o NH2 65 UPLC : Rt = 1 . 77 , 1 . 84 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C20H16CIN40 [ M + H ] " : 
m / z = 363 . 1 , found m / z = 363 . 4 . 
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6 - amino - 3 - benzyl - 4 - ( 2 , 4 - dimethylphenyl ) - 1 , 4 - dihy 6 - amino - 3 - benzyl - 4 - phenyl - 1 , 4 - dihydropyrano [ 2 , 3 
dropyrano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile ( 180 ) c ] pyrazole - 5 - carbonitrile ( 12f ) 
= 
O NH2 
E 
o NH UPLC : Rt = 1 . 81 , 1 . 87 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C20H , N40 , [ M + H ] : 
m / z = 329 . 1 , found m / z = 329 . 3 . UPLC : Rt = 1 . 85 , 1 . 94 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C22H21N40 [ M + H ] " : 
m / z = 357 . 2 , found m / z = 357 . 5 . 6 - amino - 3 - benzyl - 4 - ( p - tolyl ) - 1 , 4 - dihydropyrano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile ( 12g ) 
25 6 - amino - 3 - benzyl - 4 - ( 3 - nitrophenyl ) - 1 , 4 - dihydropy . 
rano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile ( 120 ) 
30 
NO2 
35 
O NH2 
O NH2 
40 UPLC : Rt = 1 . 72 , 1 . 78 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C21H , N _ 0 [ M + H ] " : 
m / z = 343 . 2 , found m / z = 343 . 3 . UPLC : Rt = 1 . 65 , 1 . 68 ( 2 , 4 - diydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C20H16N302 [ M + H ] " : 
m / z = 374 . 1 , found m / z = 374 . 4 . 45 
6 - amino - 4 - ( 4 - methoxy - 2 , 3 - dimethylphenyl ) - 3 
methyl - 1 , 4 - dihydropyrano [ 2 , 3 - c ] pyrazole - 5 - carboni 
trile ( 12h ) 
6 - amino - 3 - benzyl - 4 - ( 3 - fluorophenyl ) - 1 , 4 - dihydro 
pyrano [ 2 , 3 - c ] pyrazole - 5 - carbonitrile ( 12e ) 
50 
55 
CN 
60 
O NH2 N Ó NH2 
UPLC : Rt = 1 . 47 ( 2 , 4 - dihydro tautomer seen as a shoul 
65 der ) . UPLC : Rt = 1 . 68 , 1 . 74 ( 2 , 4 - dihydro tautomer ) . 
UPLC - MS ( ESI ) calculated for C20H16FN40 [ M + H ] : 
m / z = 347 . 1 , found m / z = 347 . 4 . UPLC - MS ( ESI ) calculated for C , H19N402 [ M + H ] " : m / z = 311 . 2 , found m / z = 311 . 1 . 
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SEQUENCE LISTING 
< 160 > NUMBER OF SEQ ID NOS : 4 
A 
< 210 > SEQ ID NO 1 
< 211 > LENGTH : 5 
< 212 > TYPE : PRT 
< 213 > ORGANISM : Artificial Sequence 
20 > FEATURE : 
< 223 > OTHER INFORMATION : Description of Artificial Sequence : Synthetic 
peptide 
< 220 > FEATURE : 
< 221 > NAME / KEY : MOD _ RES 
2 > LOCATION : ( 2 ) . . ( 2 ) 
< 223 > OTHER INFORMATION : Tyr ( tBu ) 
< 220 > FEATURE : 
< 221 > NAME / KEY : MOD _ RES 
< 222 > LOCATION : ( 3 ) . . ( 3 ) 
23 > OTHER INFORMATION : Arg ( Pbf ) 
< 220 > FEATURE : 
< 221 > NAME / KEY : MOD _ RES 
< 222 > LOCATION : ( 5 ) . . ( 5 ) 
3 > OTHER INFORMATION : Tyr ( tBu ) 
< 220 > FEATURE : 
< 223 > OTHER INFORMATION : C - term NHNH2 
N A 
N ~ A 
< 400 > SEQUENCE : 1 
Leu Tyr Arg Ala Tyr 
V 
V 
V 
< 210 > SEQ ID NO 2 
< 211 > LENGTH : 5 
< 212 > TYPE : PRT 
< 213 > ORGANISM : Artificial Sequence 
< 220 > FEATURE : 
< 223 > OTHER INFORMATION : Description of Artificial Sequence : Synthetic 
peptide 
< 220 > FEATURE : 
< 223 > OTHER INFORMATION : C - term NHNH2 
V
< 400 > SEQUENCE : 2 
Leu Tyr Arg Ala Tyr 
? 
? 
? 
? 
< 210 > SEQ ID NO 3 
< 211 > LENGTH : 10 
< 212 > TYPE : PRT 
< 213 > ORGANISM : Artificial Sequence 
< 220 > FEATURE : 
< 223 > OTHER INFORMATION : Description of Artificial Sequence : Synthetic 
peptide 
? 
? 
< 400 > SEQUENCE : 3 
Leu Tyr Arg Ala Tyr Cys Lys Tyr Met His 
1 10 5 
< 210 > SEQ ID NO 4 
< 211 > LENGTH : 5 
< 212 > TYPE : PRT 
< 213 > ORGANISM : Artificial Sequence 
< 220 > FEATURE : 
< 223 > OTHER INFORMATION : Description of Artificial Sequence : Synthetic 
peptide 
< 400 > SEQUENCE : 4 
Cys Lys Tyr Met His 
5 
99 
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The invention claimed is : 5 . A solid phase having a formula of : 
1 . A photolabile hydrazine linker having the formula I : 
NO2 
HN - NHPG 
NH NHR 10 
R * 
wherein 
is a functionalized solid support ; 
NO2 
wherein R * is OR ' , wherein R ' is hydrogen , C1 -12 alkyl , 
substituted C1 - 10 alkyl , aryl , substituted aryl , het - 15 
eroaryl , substituted heteroaryl or ( CH2CH2 - 
0 - mi 
R is hydrogen or a protection group ; 
m is an integer from 1 - 100 ; and n is an integer from 1 to 20 
10 . 
2 . The photolabile hydrazine linker according to claim 1 , 
wherein R * is OH and R is hydrogen or a protecting group . 
3 . The photolabile hydrazine linker according to claim 1 , 
wherein n is an integer from 2 to 5 , or from 3 to 5 or n is 3 . 
4 . A method for the synthesis of a photolabile hydrazine 
linker according to claim 1 , wherein R * is OH and R is a 
protecting group , comprising the steps of 
a ) reacting a compound of formula 2 : 
HN - NHPG 
mi 
30 
NO2 
is a photolabile hydrazine linker , wherein n is an integer 
from 1 to 10 ; and 
PG is a protecting group . 
6 . The solid phase according to claim 5 , wherein the 
connection between the functionalized solid support and the 
photolabile hydrazine linker comprises a spacer and / or an 
orthogonally cleavable linker . 
7 . The solid phase according to claim 5 , wherein 
5 
o R — Ó 40 
wherein R ' is alkyl or substituted alkyl , n is an integer 
from 1 to 10 with PG - carbazate , where PG is a pro 
tecting group to obtain a compound of formula 3 : is a solid support functionalized with a group selected from 
45 amino , hydroxy , carboxy , acrylo , maleimido , halo ( chloro , 
bromo , iodo ) , azido , alkynyl , alkenyl , and nitro . 
8 . The solid phase according to claim 5 having the 
following formula : NO2 
50 
HN - NHPG 
R - O 
HN - NHPG b ) hydrolyzing the compound of formula 3 to obtain a 55 
compound of formula 4 : NH al 
wherein NO 
60 
- NH NH | HN - NHPG . 
?? 65 is an amino - functionalized solid support . 
9 . The solid phase according to claim 5 , wherein PG is a 
protecting group selected from the group comprising Cbz 
101 
NO 
US 9 , 850 , 275 B2 
102 
( Z ) , multiple substituted methoxy - , nitro - , or chloro Cbz 14 . A method for the solid phase peptide synthesis ( SPPS ) 
( including Z ( 4 - MeO ) , Z ( 2 - NO2 ) , Z ( 4 - NO2 ) , Z ( 2 - C1 ), Z ( 3 - of peptide hydrazides , comprising the steps of : 
CI ), Z ( 2 , 4 - C1 ) , Z ( 3 , 5 - 0Me ) ) , Ddz , Nvoc , Pz , Tmz , Bic , a ) Providing a solid phase according to claim 11 , 
Bpoc , Azoc , iNoc Boom Cy?c , Tcboc , Adoc , Adpoc , Iboc , b ) Coupling a first N - protected amino acid moiety to said Fmoc , Tsoc , Msc , Nsc , Bspoc , Bsmoc , Mspoc , Aloc , Teoc , 5 immobilized hydrazine - functionalized photolabile Tipseoc , Pipoc , Poc , PTnm , Epoc , Mtr , Pmc , Pbf , Trt , linker , 2 - C1 - Trt , Dmt , Tmob , Tfa , Tos , o - Nbs , p - Nbs , dNBS , Bts , c ) Deprotecting said coupled N - protected amino acid Nps , Dde , Nde , Trt , Bzl , Acm . moiety , 
10 . A method for the synthesis of a solid phase , compris - 10 d ) Coupling a second N - protected amino acid moiety to ing a step of reacting a functionalized solid support with a said immobilized amino acid moiety , photolabile hydrazine linker according to claim 1 , wherein 
R * is OH and R is a protecting group . e ) Deprotecting said coupled N - protected amino acid moiety , 11 . A solid phase having a formula of : 15 f ) repeating said coupling and deprotection steps d and e 
as many times as necessary to synthesize an immobi 
lized peptide as desired , 
g ) cleaving said immobilized peptide from the solid 
support by irradiation of the photolabile linker to obtain 
20 the peptide hydrazide . 
| HN – NH2 15 . A method according to claim 14 , wherein cleaving in 
step g ) is performed in acetone / CH , CN to obtain the acetone 
protected peptide hydrazide , which optionally is deprotected 
in the presence of water . 
16 . A method according to claim 14 , wherein the amino wherein acid moiety is selected among any natural and synthetic 
amino acids and derivatives thereof , preferable among the 
naturally occurring amino acids . 
30 17 . A method for the synthesis of oligo - or polypeptides , 
comprising the steps of : 
a ) obtaining a peptide hydrazide or acetone hydrazone 
is a functionalized solid support , protected peptide hydrazide in a method according to 
claim 14 , and 
b ) Coupling said peptide hydrazide with a peptide in a 
ligation reaction to obtain an oligo - or polypeptide . 
18 . A method for the synthesis of dihydropyrano [ 2 , 3 - c ] 
pyrazoles of the formula : 
HN - NH 40 
25 
35 
NO2 
mm NH2 
45 
R3 
is a photolabile hydrazine linker , wherein n is an integer * 
from 1 to 10 ; and 
the connection between the solid support and the pho 
tolabile hydrazine linker optionally comprises a 
spacer and / or an orthogonally cleavable linker . 50 
12 . The solid phase according to claim 11 having the 
formula 
wherein R , is selected from C1 - 3 alkyl , substituted C1 - 8 
alkyl , aryl , substituted aryl , heteroaryl and substituted 
heteroaryl and R , is selected from aryl , substituted aryl , 
heteroaryl and substituted heteroaryl comprising the 
steps of : 
a ) providing a solid phase according to claim 11 , 
b ) reacting said hydrazine - functionalized photolabile 
linker with a B - keto ester with the formula : 
55 
alo | HN - NH . 60 R - NH NH 
13 . A method for the synthesis of a solid phase comprising 
an immobilized hydrazine - functionalized photolabile linker , 65 
comprising the step of removing the protecting group from 
the solid phase according to claim 5 . 
wherein R2 is C1 - 8 alkyl or substituted C1 - 8 alkyl , 
preferably methyl or ethyl , to obtain an immobilized 
1H - pyrazol - 5 ( 4H ) - one with formula : 
US 9 , 850 , 275 B2 
103 104 
NO2 
10 
c ) reacting the 1H - pyrazol - 5 ( 4H ) - one with an aldehyde 
R3 - CO , wherein Rz is selected from aryl , substituted 
aryl , heteroaryl and substituted heteroaryl , in the pres - 15 
ence of malononitrile to obtain an immobilized dihy dropyrano [ 2 , 3 - c ] pyrazole with the formula : 
NO2 20 
NH2 deres 25 R3 R1 
d ) cleaving said immobilized peptide from the solid 30 
support by irradiation of the photolabile linker to obtain 
the dihydropyrano [ 2 , 3 - c ] pyrazole . 
* * * * 
